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Abstract 72 
BACterial Hosts for production of Bioactive phenolics from bERRY fruits (BacHBerry) was a three-year 73 
project funded by the Seventh Framework Programme (FP7) of the European Union that ran between 74 
November 2013 and October 2016. The overall aim of the project was to establish a sustainable and 75 
economically-feasible strategy for the production of novel high-value phenolic compounds isolated from 76 
berry fruits using bacterial platforms. The project aimed at covering all stages of the discovery and pre-77 
commercialization process, including berry collection, screening and characterization of their bioactive 78 
components, identification and functional characterization of the corresponding biosynthetic pathways, and 79 
construction of Gram-positive bacterial cell factories producing phenolic compounds. Further activities 80 
included optimization of polyphenol extraction methods from bacterial cultures, scale-up of production by 81 
fermentation up to pilot scale, as well as societal and economic analyses of the processes. This review article 82 
summarizes some of the key findings obtained throughout the duration of the project. 83 
  84 
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Introduction 85 
BacHBerry (BACterial Hosts for production of Bioactive phenolics from bERRY fruits, www.bachberry.eu) 86 
has received funding from the European Commission’s Seventh Framework Programme (FP7) under the 87 
theme KBBE.2013.3.1-01: “Plant High Value Products - from discovery to final product” with the goal of 88 
bringing together experts from the fields of plant biology, industrial biotechnology, analytical chemistry, and 89 
social sciences in order to assemble and validate a complete pipeline for discovery and microbial production 90 
of novel phenolic compounds of plant origin. The consortium consisted of twelve academic groups, five 91 
small and medium sized enterprises and one large enterprise from eleven different countries, namely Austria, 92 
Chile, China, Denmark, France, Germany, The Netherlands, Portugal, Russia, Switzerland and the United 93 
Kingdom. The diversity of partners has allowed access to a variety of expertise and to plant material that had 94 
not been characterized extensively. 95 
Polyphenols as a source of bioactive molecules  96 
Historically, plants have been not only important sources of nutrients and energy in the human diet but also 97 
have provided the fundamentals of traditional and modern medicine. The Plantae kingdom has been 98 
estimated to produce more than 200,000 different chemical compounds (Weckwerth 2003), including 99 
compounds with proven and potential medical applications. This is reflected in the high number of 100 
pharmaceutical products based on, or derived from, plant natural products, such as aspirin, morphine, 101 
quinine, paclitaxel and artemisinin (Cragg and Newman 2013). Among the different classes of specialized 102 
(i.e. secondary) metabolites phenylpropanoids stand out due to their diversity and ubiquity in the plant 103 
kingdom. Fleshy fruits, a rich source of bioactive components, such as ascorbate (vitamin C), terpenoids and 104 
polyphenols, are considered to have one the highest antioxidant capacity of commonly eaten foods 105 
(Halvorsen et al. 2006). Polyphenol content and composition can vary substantially between fleshy-fruit 106 
varieties (Carvalho et al. 2013; Miladinović et al. 2014; Kula et al. 2016), different cultivation conditions 107 
(Josuttis et al. 2013; Vagiri et al. 2013; Mazur et al. 2014), harvest times and as a result of different post-108 
harvest factors (Kårlund et al. 2014; Stavang et al. 2015), but particularly between species (Moyer et al. 109 
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2001; McDougall et al. 2008; Ruiz et al. 2010; Marhuenda et al. 2016). Furthermore, plant polyphenols are 110 
increasingly being associated with putative bioactivities offering protection against several cardiovascular 111 
(Goszcz et al. 2015) and neurological diseases (Figueira et al. in press). 112 
The hydroxystilbenes are a group of polyphenols with a C6-C2-C6 skeleton with two or more hydroxyl 113 
groups, where a central carbon–carbon double bond is conjugated with two phenolic moieties (Quideau et al. 114 
2011; Kasiotis et al. 2013). The most well-known representative of this group is resveratrol (trans-3,5,4’-115 
hydroxystilbene) (Figure 1a). The compound has gained increasing attention with the discovery of the 116 
“French paradox”, an observation that despite a diet with relatively high amounts of saturated fats, French 117 
people suffer a relatively low incidence of mortality from coronary heart disease (Renaud and de Lorgeril 118 
1992; Catalgol et al. 2012). Like other polyphenols, stilbenes can be further decorated by O-methylation (e.g. 119 
resulting in 3-methoxy-resveratrol, or pinostilbene, and 3,5’-dimethoxy-resveratrol, or pterostilbene), 120 
acylation (hydrangenic acid) or by glycosylation (e.g. piceid and resveratroloside) (Kim et al. 2002; Becker 121 
et al. 2003; Zhang et al. 2009; Wang et al. 2015). 122 
The flavonoids are one of the largest families of phenolic compounds. Flavonoids are characterized by their 123 
basic skeleton composed of three rings (Ghosh and Scheepens 2009), including two benzene rings (A & B) 124 
and one heterocyclic ring (C) (Figure 1b). So far, over 5,000 naturally occurring flavonoids have been 125 
characterized from various plants and they have been classified into six subgroups, including anthocyanidins 126 
(e.g. cyanidin and delphinidin); flavan-3-ols (e.g. catechin and epicatechin); flavonols (e.g. quercetin and 127 
kaempferol); flavones (e.g. luteonin and apigenin); isoflavones (e.g. genistein and daidzein), and flavanones 128 
(e.g. hesperetin and naringenin). 129 
Within each subgroup, considerable variation can exist when it comes to phenolic composition of different 130 
fruits, and in particular of berries. Anthocyanin composition provides an excellent example of this diversity: 131 
the red-orange color of strawberries is due to the presence of pelargonidin-type anthocyanins in the flesh and 132 
skin whereas the deep purple-black color of blackcurrants is due to the accumulation of high amounts of 133 
delphinidin and cyanidin-type anthocyanins in the skin. 134 
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Anthocyanidins are flavonoids, which are characterized by a hydroxyl group in position 3 and a C-ring with 135 
a positively-charged oxonium ion (Figure 1b). Anthocyanins are water-soluble glycosides of 136 
anthocyanidins, in which sugars, consisting of one or more hexoses, are linked to the 3-hydroxyl group of the 137 
pyrylium ring (Heldt and Piechulla 2011). These compounds are responsible for the orange/red-to-blue 138 
coloration observed in some plants. The most common anthocyanidins include cyanidin (red), delphinidin 139 
(bluish-purple), malvinidin (reddish-purple), pelargonidin (orange-red), peonidin (pink) and petunidin 140 
(purple). The distribution of anthocyanidins can vary greatly among different berry species (Table 1). 141 
Flavonoid compounds frequently are decorated with sugar moieties, sugar-acyl moieties (Giusti and 142 
Wrolstad 2003) and can be associated with other flavonoids. The patterns of decoration differ greatly 143 
amongst species (see Supplementary Tables S1 and S2).  144 
Flavonoids are far more prevalent and diverse in berry species than in other common fruits and vegetables. 145 
High flavonol contents are observed in cranberry, lingonberry and blackcurrant (Häkkinen et al. 1999), 146 
anthocyanins are the most abundant polyphenol pigments (2-5 g kg-1 fresh weight) in berries (Määttä et al. 147 
2001) and many simple phenolic acids are abundant in a wide range of berry species (Herrmann and Nagel 148 
1989). Additionally, berries constitute one the most important dietary sources of ellagitannins such as 149 
sanguiin H6, lambertianin C (Törrönen 2009; Landete 2011) and condensed tannins such as the 150 
proanthocyanidins (Rasmussen et al. 2005; Hellström et al. 2009). Stilbenes, in contrast, are not that 151 
widespread in berries: resveratrol shows highest abundance in grapes (up to 20-30 mg kg-1 fresh weight), but 152 
small amounts of resveratrol, pterostilbene and piceatannol have been also detected in blueberry, cowberry, 153 
cranberry, deerberry and lingonberry (Jeandet et al. 1991; Paredes-López et al. 2010; Manganaris et al. 154 
2014). It is clear that soft-fruit species contain a staggering diversity of distinct polyphenol derivatives whose 155 
potential is yet to be harnessed. 156 
The market for polyphenolic compounds has seen substantial growth over the past few years, and is expected 157 
to exceed 850 million USD by 2018 (Aranaz et al. 2016). The major factors contributing to this trend are the 158 
growing consumer awareness regarding the benefits of polyphenol consumption and the increasing use of 159 
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polyphenol-containing extracts in food, beverage, and cosmetics products particularly in Asia (Jain and 160 
Ramawat 2013; Aranaz et al. 2016; Grand View Research Inc. 2016). The increase in demand also requires 161 
efficient and eco-friendly production processes, to improve on current manufacturing practices that mostly 162 
rely on extraction from various plant sources (e.g. roots, leaves or fruits) via complex downstream 163 
processing (Wang et al. 2016a). The BacHBerry consortium decided to address these challenges and set the 164 
following objectives: (i) to systematically analyze the phenolic contents in the large berry germplasm 165 
collections available from consortium members, (ii) to establish a publicly-available database of 166 
transcriptomic and metabolic data obtained from berry bioprospecting within, as well as outside of the 167 
project, (iii) to discover novel bioactivities in berry extracts against a range of human pathologies, such as 168 
Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS), by high-throughput screening with 169 
subsequent identification of functional biomolecules, (iv) to identify the corresponding biosynthetic genes 170 
and perform functional characterization of the respective gene products, (v) to assay a selection of the 171 
biosynthetic genes for functionality in Gram-positive bacterial hosts and use those to construct bacterial cell 172 
factories for phenolic production, (vi) to improve the production efficiency further by introducing 173 
modifications to the host metabolic networks predicted via rational design or computational tools developed 174 
within the project, (vii) to design and optimize cost-effective food-grade methods for extraction of phenolic 175 
compounds from bacterial fermentation broth, and (viii) to optimize fermentation conditions and 176 
subsequently upscale the production to pilot plant levels. 177 
The project commenced with the selection, sampling and whole-metabolite profiling of berries. In order to 178 
explore the potential of the phytochemical diversity present in different berry species, we undertook an 179 
untargeted characterization of a wide collection of berries from different species/cultivars utilizing 180 
metabolomics-based methods to aid the selection of candidate berry extracts for bioactivity screening. 181 
Phytochemical diversity in sampled berries 182 
Although significant advances have been made in characterizing the polyphenolic complement of berries, 183 
particularly in the context of cultivated species and genotypes, there is limited literature available regarding 184 
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the phytochemical composition of wild and underutilized species/cultivars. Indeed, wild berries are 185 
commonly reported as particularly rich in diverse phenolic compounds, often as a result of phenolic-186 
associated astringency having been bred out of cultivated species (Häkkinen et al. 1999). The phenolic 187 
diversity of individual berries has been highlighted in many publications (Määttä et al. 2003; Zadernowski et 188 
al. 2005; Milivojević et al. 2011), but studies that capture this broad diversity systematically are limited. In 189 
BacHBerry, we aimed not only to address this knowledge gap but also to go beyond the state-of-the-art by 190 
combining analyses of phenolic diversity with functional testing of berry extracts. The genera targeted in this 191 
study included Rubus, Ribes, Vaccinium, Lonicera, Lycium, Aristotelia, Berberis and Ugni collected from 192 
different locations in the world including Chile, China, Portugal, Russia and United Kingdom (see 193 
Supplementary Table S3).  194 
Berry extract metabolite profiling  195 
Fruit samples from a total of 112 species/genotypes were collected, extracted, and subsequently subjected to 196 
liquid-chromatography mass-spectrometry (LC-MS) metabolomic analysis (see details in Supplementary 197 
Materials S1). An untargeted method was used to generate a total of 1,890 mass spectral features (1,506 and 198 
384 in positive and negative modes, respectively), which were integrated to generate the dataset used for 199 
statistical analysis. Principal component analysis (PCA) was used as a multivariate statistical analysis tool to 200 
identify those species, which had the most distinct phytochemical profiles (Figures 2a and 2b). 201 
Using the four principal components it was possible to select the species/genotypes, which represented the 202 
broadest phenolic diversity (Table 2). In addition to selecting the outlier groups of species, it was also 203 
decided to include a small subset of samples (two Rubus idaeus genotypes), which did not separate from the 204 
majority of samples in the first principal components. This provided samples with phenolic profiles distinct 205 
from the outlier samples and standards for comparison between uncultivated/underutilized species and 206 
commonly grown species; in essence a commercial control. The fruits from the selected species (Table 2) 207 
were extracted and tested for bioactivity in yeast (Saccharomyces cerevisiae) models for pathological 208 
processes associated with several chronic disorders.  209 
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Berry extract bioactivity screening  210 
Evidence for the protective role of polyphenols against chronic diseases has increased over the past 20 years 211 
(Figueira et al. in press; Goszcz et al. 2015). Neurodegenerative diseases (NDs) represent a group of chronic 212 
neurological conditions affecting millions of people worldwide, among which are the Alzheimer's Disease 213 
(AD), the Parkinson's Disease (PD), the Huntington's Disease (HD), and Amyotrophic Lateral Sclerosis 214 
(ALS). All these diseases have in common the aggregation and deposition of protein aggregates, namely of 215 
amyloid β42 (Aβ42) (O’Brien and Wong 2011), αSynuclenin (αSyn) (Shults 2006), huntingtin (HTT) 216 
(Miller-Fleming et al. 2008) and FUsed in Sarcoma (FUS) (Kwiatkowski et al. 2009; Vance et al. 2009), 217 
which represent the pathological hallmarks of AD, PD, HD and ALS, respectively. In addition, chronic 218 
activation of innate immune responses is a process closely associated with neurodegeneration. Its modulation 219 
is driven by persistent activation of key transcription factors, such as the Nuclear Factor of Activated T-cells 220 
(NFAT) and Nuclear Factor κB (NFκB), which upregulate pro-inflammatory responses creating a positive 221 
feedback loop further amplifying initial stimuli. It has been argued that disruption of this loop may represent 222 
an important strategy to mitigate the progression of NDs. The pleiotropic effects of polyphenols have been 223 
shown to interfere with aggregation-driven neurodegeneration as well as to attenuate chronic inflammatory 224 
processes, thereby improving health of cellular and animal models (Figueira et al, in press). Consequently, 225 
polyphenol-based therapies represent an underexplored strategy to minimize the huge social and economic 226 
impact of NDs. 227 
The high degree of evolutionary conservation of fundamental biological processes among eukaryotes has 228 
established yeast as a validated model organism to decipher the intricacies of human pathologies, particularly 229 
NDs, to identify molecular targets amenable to therapeutic intervention as well as lead molecules with 230 
health-promoting potential (Kritzer et al. 2009; Su et al. 2010; Tardiff et al. 2012; Menezes et al. 2015). 231 
BacHBerry aimed at identifying phenolic bioactives from harnessing the diversity of phenolics in selected 232 
berry germplasm from cultivated, wild and underutilized species of berries. The yeast-based screening 233 
platform for bioactivity identification comprised a set of genetically modified S. cerevisiae strains expressing 234 
Green Fluorescent Protein (GFP) fused with Aβ42 (Bharadwaj et al. 2010), αSyn (Outeiro and Lindquist 235 
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2003), HTT (Krobitsch and Lindquist 2000) and FUS (Ju et al. 2011) under the control of a galactose-236 
inducible promoter (Figure 3a). Upon activation of expression, these proteins start forming aggregates, 237 
which consequently has a negative impact on cellular growth and results in lower GFP fluorescence levels. 238 
In case an extract possesses bioactivity against one of the diseases, addition of the extract to the activated 239 
yeast cells reduces growth inhibition in the corresponding model. These yeast strains accelerated the 240 
identification of phenolic compounds with health-promoting attributes among the most chemically diverse 241 
samples identified by the metabolomic analysis (Table 2). For information on the procedures used during the 242 
screening see Supplementary Materials S1. 243 
An illustrative example of how bioactivities for AD were identified is given in Figure 4a.  Upon shift of 244 
cells to galactose medium to induce expression of GFP-Aβ42, yeast growth was impaired in comparison to 245 
the control strain indicating GFP-Aβ42 proteotoxicity. The treatment with polyphenol-enriched extracts of 246 
Lycium chinense significantly recovered growth of these cells revealing its protective role via modulation of 247 
Aβ42 toxicity. The bioactivities for PD, HD and ALS were screened using a similar approach, in cells 248 
expressing the respective disease proteins.  249 
In addition, we have also used a yeast-based model for inflammatory signaling that is based on a Crz1 250 
reporter-strain (Prescott et al. 2012; Garcia et al. 2016) (Figure 3b). Crz1 is a yeast orthologue of NFAT, 251 
which is an important modulator of inflammation in humans that is known to be involved in development of 252 
multiple disorders, such as the inflammatory bowel disease or the rheumatoid arthritis (Pan et al. 2013). Both 253 
Crz1 and NFAT are known to be activated by a serine/threonine protein phosphatase calcineurin (CaN) in a 254 
Ca2+-dependent manner (Rusnak and Mertz 2000; Bodvard et al. 2013). The utilized reporter strain encodes 255 
the β-galactosidase gene (lacZ) under the control of a promoter bearing Crz1-binding sites, the Calcineurin-256 
Dependent Responsive Element (CDRE), allowing the assessment of Crz1 activation through the 257 
measurement of β-galactosidase activity using chromogenic substrates (Garcia et al. 2016). Given the 258 
evolutionary conservation of NFAT and Crz1 activation mechanisms, in combination with the conserved 259 
activity of the immunosuppressant FK506 both in yeast and in humans, the yeast Ca2+/CaN/Crz1 reporter 260 
assay represents a reliable tool to identify bioactives with potential to attenuate NFAT-mediated 261 
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inflammatory responses. The potential of Lycium chinense polyphenol-enriched extracts to attenuate 262 
inflammation is shown in Figure 4b, exemplifying the approach used in BacHBerry to filter for potential 263 
anti-inflammatory activities. The activation of Crz1 by MnCl2, mimicking NFAT activation, led to high β-264 
galactosidase activity and cell treatment with FK506 and Lycium chinense extract strongly reduced the β-265 
galactosidase levels revealing its ability to modulate Crz1, and potentially NFAT, activation.  266 
These examples illustrate the strategy used in the BacHBerry project to search for bioactive compounds 267 
interfering with pathological processes of NDs and inflammation. The yeast-based screening platform also 268 
included strains allowing the identification of metabolites with potential application for type II diabetes, 269 
hematological diseases and cancer (unpublished results). 270 
Bioassay-guided fractionation compound discovery and candidate compound validation 271 
This method of discovering new bioactive natural products ultimately depends on the availability of 272 
biological material and preparative- or semi-preparative-scale analytical methods with the capability of 273 
resolving mixtures of different classes of compounds  typically present in berry extracts (Pauli et al. 2012). 274 
Semi-preparative chromatography was used to fractionate selected berry extracts with potential bioactive 275 
properties using a hybrid approach of bioassay-guided fractionation procedure (Yang et al. 2001; Weller and 276 
G. 2012; Tayarani-Najaran et al. 2013) and screening of pure compounds (Watts et al. 2010). Bioassay-277 
guided fractionation typically involves the following steps: assessment of bioactivity, extraction of the 278 
biological material with different solvents and testing of bioactivity. Once bioactivity of an extract has been 279 
validated, the extract gets subjected to an iterative process of sub-fractionation/bioactivity testing until pure 280 
bioactive natural products are obtained for structural characterization. This approach benefits from exclusion 281 
of extracts that do not have bioactivity. However, this procedure requires extensive use of biological material 282 
and expensive materials and may result in the isolation of already-known natural products (Duarte et al. 283 
2012). Another disadvantage is that the approach is based on the assumption that bioactivity is conferred by 284 
a pure compound, although this method can also be used for identification of bioactivities conferred by a 285 
cumulative interactions of several polyphenols. Alternatively, pure-compound screening relies on an initial 286 
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isolation and structural elucidation of the individual compounds present in the biological extract followed by 287 
bioassay screening. This strategy allows the researcher to focus solely on novel compounds, without re-288 
discovering compounds with well-annotated bioactivity. However, it may also lead to the identification of 289 
novel compounds with no bioactivity (Duarte et al. 2012). The second method misses any synergistic 290 
interactions affecting bioactivities of berry phenolics. 291 
The limited amount of biological material available restricted the number of iterations of fractionation and 292 
re-testing of fraction bioactivity possible for typical bioassay-guided fractionation approaches. As described 293 
previously, berry extracts typically comprise a relatively diverse and large pool of metabolites that surpass 294 
by far the throughput capability of the bioactivity assays used in this study. To overcome these challenges, a 295 
hybrid approach was adopted which consisted of several steps: (i) assessment of potential bioactivity present 296 
in extracts (as described above), (ii) fractionation of bioactive extracts (see Supplementary Materials S1), 297 
(iii) assessment of potential bioactivity present in fractions, (iv) mass-spectrometry-based chemical 298 
characterization of bioactive fractions, (v) bioactivity testing of pure candidate compounds (Figure 5). 299 
Although this approach shared some of the limitations of the other approaches, it did allow for the exclusion 300 
of non-bioactive biological extracts or fractions and focused on the identification novel compounds with 301 
potential bioactivities with limited requirement for biological material.  302 
Following fractionation of the most promising berry extracts from the first round of screening using the 303 
yeast-based platform, isolated fractions were re-analyzed in order to detect bioactive fractions. Subsequently, 304 
metabolomic analyses were used for the identification of the individual compounds in each of the bioactive 305 
fractions. By utilizing this approach, a set of candidate compounds was defined and re-tested as pure 306 
compounds in the yeast-based platform, with further bioactivity validation in the mammalian cell models. 307 
Following the BacHBerry pipeline, this information then served as starting point for the engineering of the 308 
synthetic pathway for biosynthesis of one of the validated compounds in food-grade bacteria and its 309 
subsequent production in small-scale fermenters. The final step of the pipeline, namely re-confirmation of 310 
bioactivity of microbially-produced compounds extracted from fermentation broth in both yeast and and 311 
mammalian cell models, is currently underway.  312 
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Identification of metabolic pathways and regulators involved in phenolic production 313 
The next step within the BacHBerry pipeline involved the identification of the biosynthetic genes and 314 
pathways corresponding to the newly discovered bioactives, in order to establish production of these 315 
compounds in bacterial hosts. In plants, the biosynthesis of polyphenols occurs via the phenylpropanoid 316 
pathway, where the aromatic amino acid L-phenylalanine serves as a precursor. Depending on the enzyme 317 
combination, several compounds can be produced in bacteria, including cinnamic acid derivatives, lignin 318 
subunits, lignans, phenylpropenes and coumarins, all sharing a basic C6-C3 skeleton (Vogt 2010). 319 
Furthermore, the phenylpropanoid backbone can be extended with up to three acetyl-units derived from 320 
malonyl-CoA by chalcone synthase (CHS) or stilbene synthase (STS), polyketide synthases which generate 321 
various polyketides, such as flavonoids and stilbenes. The core pathways of phenolic biosynthesis are very 322 
well understood, with common enzymes, such as, phenylalanine ammonia lyase (PAL), cinnamate 4-323 
hydroxylase (C4H), p-coumaroyl CoA ligase (4CL),  hydroxycinnamoyl-CoA shikimate/quinate 324 
hydroxycinnamoyltransferase (HCT), p-coumaroyl shikimate/quinate 3'-hydroxylase (C3’H), stilbene 325 
synthase  and chalcone synthase, found in many plant species (Figure 6).  326 
Phenolic chemodiversity in berries, as in other plants, derives from a variety of decorations to the backbone 327 
of phenolic structures that include hydroxylations, O-methylations, prenylations, aryl migrations, 328 
glycosylations, acylations and polymerizations. For example, anthocyanins are glycosylated on 3-OH 329 
positions of the C-ring (Figure 1) and many harbor additional glycosyl groups (for example 5’-O-330 
glycosylation and 3’-O-glycosylation), methoxy groups (petunidin and malvinidin), or hydroxyl groups 331 
(which differentiate pelargonidin, cyanidin and delphinidin (Figure 6 and Table 1)). These decorations may 332 
affect the bioavailability, bioactivity and stability of polyphenolic compounds. It is therefore essential to 333 
develop a greater knowledge of the decorating enzymes specific to berry bioactives, such as those 334 
differentially decorating anthocyanins, flavonols, stilbenes, or condensed tannins. Many genes encoding 335 
enzymes involved in flavonol and anthocyanin decoration have already been characterized not only in 336 
planta, but also heterologously in microorganisms, such as Escherichia coli and S. cerevisiae (Tohge et al. 337 
2005; Luo et al. 2007; Pandey et al. 2016; Wang et al. 2016a). 338 
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Berry bioactives identified within the project had special decorations, and those where the genes encoding 339 
the decorating activities had not been previously identified, required further research. In a recent work, the 340 
transcriptome of the commercial blueberry (Vaccinium corymbosum) was studied using RNA sequencing 341 
technology (RNA-seq) in order to discover putative genes related to antioxidant production using next-342 
generation sequencing (NGS) (Li et al. 2012). Similarly, we aimed to identify decorating enzymes and 343 
regulators of the biosynthetic pathways of berry bioactives by obtaining transcriptome sequences of target 344 
species at different stages of fruit development. This information was used to construct a database of 345 
transcriptome sequences for a broad range of berry species, especially those identified as target species 346 
containing the promising bioactive molecules. In addition, the overall production of polyphenols is regulated 347 
by a range of transcription factors and these were also investigated within the BacHBerry project, with the 348 
objective of identifying markers for breeding enhanced levels of phenolic bioactives using the diverse 349 
germplasm in selected berry species. 350 
Firstly, a library of reference sequences consisting of plant gene sequences encoding enzymes of the core 351 
phenolic biosynthetic pathways, which was subsequently used for BLAST searches of berry transcriptomes, 352 
was compiled. This library included well-known and experimentally validated anthocyanin, flavonol, 353 
stilbene and catechin biosynthetic enzymes from a wide range of plant species. Next, 13 germplasms 354 
spanning eight genera, seven families and seven orders were selected for RNA-seq of berry transcriptomes. 355 
Sequencing of selected berries at different stages of maturation was also conducted. The data have provided 356 
significant resources not only for understanding phenolic biosynthesis in berries, but also for investigating 357 
commonalities in genes expressed in berries (Table 3). 358 
Multi-layer comparisons of the metabolomics and transcriptomics data of developmental stages, and 359 
targeted, as well as, non-targeted searches of candidate transcripts were performed to elucidate genes 360 
involved in specific phenolics biosynthetic pathways. Analyses of expression of these genes from different 361 
developmental stages of selected berry species were performed with the expVIP tool (Borrill et al. 2016). 362 
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These data were used to search for genes encoding putative decorating enzymes based on the list of 363 
molecules of potential interest as bioactives and having special decorations in target berry species. 364 
Candidates were identified mostly by searching for homologues of well-characterized plant genes. This was 365 
carried out with the help of MassBlast, a software developed within the BacHBerry project 366 
(https://github.com/averissimo/mass-blast; (Veríssimo et al. submitted)). We annotated all major enzyme 367 
families, including cytochromes P450 (CYP), 2-oxoglutarate-dependent dioxygenases (2-OGDs), UDP-368 
glycosyltransferases (UGTs), BAHD acyltransferases, and O-methyltransferases (OMTs), in all 13 selected 369 
berry germplasms. Average counts per transcriptome are presented in Table 4. We also detected candidate 370 
transcript(s) for 60-80% of the known biochemical steps of the phenylpropanoid pathway, representing 371 
between 109-180 candidates per transcriptome. Approximately 40% of these candidates identified from the 372 
transcriptomes were full-length sequences. Furthermore, biochemical activities of some of enzymes encoded 373 
by the candidate genes were tested. 374 
We also looked for transcripts encoding regulators of phenolic biosynthesis. Since the R2R3-MYB gene 375 
family operates extensively in controlling phenylpropanoid metabolism in plants (Stracke et al. 2001; 376 
Hartmann et al. 2005), initial searches were focused on identifying MYB-genes that were strongly expressed 377 
in berries. However, members of the bHLH and bZIP families of transcription factors were also identified in 378 
the berry RNA-seq databases since they may also play roles in regulating accumulation of phenolic 379 
bioactives (Hartmann et al. 2005). These data could be particularly useful in breeding programs for selection 380 
of plants with improved bioactive contents. The presence of genes encoding putative transporters of phenolic 381 
compounds was also examined. Excretion of target compounds produced by bacterial hosts into the culture 382 
medium via such transporters would simplify extraction procedures, and may also be necessary in case of 383 
any toxic effects of these molecules in bacteria. One transporter is currently being characterized functionally. 384 
Gram-positive bacteria as cell factories for the efficient production of berry high-value phenolics 385 
While the search for novel bioactives was under way, a set of well-characterized biosynthetic pathway was 386 
used for establishing a platform for production of phenolic compounds in Gram-positive bacteria. Two major 387 
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criteria were used for the selection of host organisms for this task: (1) they had to be robust, well-studied 388 
organisms with a long-standing history of industrial use and (2) the bacteria must have a generally regarded 389 
as safe (GRAS) status and/or be recognized as food-grade. Two industrially-important bacteria, namely 390 
Lactococcus lactis and Corynebacterium glutamicum, appeared as attractive candidates for the sustainable 391 
production of added-value food and pharmaceutical compounds (Lahtinen et al. 2011; Jojima et al. 2013). 392 
Both L. lactis and C. glutamicum are used worldwide in numerous industrial processes, which consequently 393 
led to significant amount of research work dedicated towards improving our knowledge of their physiology 394 
and genetics. These efforts have resulted in development of large toolboxes for (heterologous) gene 395 
expression and introduction of genetic modifications in these bacteria (Burkovski 2008; Pontes et al. 2011; 396 
Gaspar et al. 2013). Furthermore, high-throughput methodologies for transcriptome, proteome and 397 
metabolome analysis, and genome-scale metabolic models are available for these species (Krömer et al. 398 
2004; Oliveira et al. 2005; Shinfuku et al. 2009; Gaspar et al. 2013). Combined with their general robustness, 399 
ease of handling and the GRAS status, both L. lactis and C. glutamicum have a strong potential for becoming 400 
platform organisms for production of polyphenolic compounds. 401 
It should also be noted that during the earlier stages of the project, E. coli was also as a platform for 402 
reconstruction of polyphenol biosynthetic pathways. E. coli has a long history of use in research on 403 
microbial-based production of various value-added chemicals. Moreover, it is one of the best studied 404 
organisms, easy to handle, and there much larger set of genetic tools is available for this organism compared 405 
to other bacteria (Yu et al. 2011; Dobson et al. 2012; Chen et al. 2013). Furthermore, E. coli has been 406 
previously used for heterologous production of polyphenolic compounds (Pandey et al. 2016; Wang et al. 407 
2016a). 408 
Lactococcus lactis 409 
L. lactis is a Gram-positive bacterium from the order of Lactobacillales that has been widely used in the food 410 
industry for the manufacturing of cheese, buttermilk and other dairy products. It is a low G+C aerotolerant 411 
bacterium with a relatively small genome and simple sugar metabolism: utilization occurs via glycolysis 412 
(Embden–Meyerhof–Parnas pathway) with lactic acid being the major end-product (Gaspar et al. 2013). Its 413 
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ability to ferment various carbohydrates, such as hexoses, pentoses and, in some strains, even complex 414 
carbohydrates of plant origin, as well as its high alcohol, acid and stress tolerance makes this bacterium 415 
suitable for the harsh environments commonly found under industrial production conditions. L. lactis strains 416 
have been engineered to produce multiple commodity chemicals (e.g. 2,3-butanediol and butanol), as well as 417 
food additives, including sweeteners (e.g. mannitol and xylitol), flavorings (e.g. acetaldehyde  and diacetyl), 418 
and vitamins. Furthermore, production of plant secondary metabolites, namely isoprenoids and stilbenes, has 419 
been demonstrated in this organism (Neves et al. 2005; Katz et al. 2011; Gaspar et al. 2013; Song et al. 420 
2014). In addition, L. lactis is well known as an excellent host for the expression of both prokaryotic and 421 
eukaryotic proteins, and has been consequently used for development of live vaccine (Kunji et al. 2005; 422 
Hernández et al. 2007; Frelet-Barrand et al. 2010; Pontes et al. 2011). 423 
As depicted in Figure 6, in plants the biosynthesis of the core intermediate of the phenylpropanoid pathway, 424 
p-coumaric acid, begins from L-phenylalanine and occurs in two steps: a deamination reaction catalyzed by 425 
phenylalanine ammonia-lyase (PAL) and a hydroxylation reaction catalyzed by cinnamate 4-hydroxylase 426 
(C4H). The latter enzyme belongs to the CYP family that is often challenging to express in active form in 427 
prokaryotic systems (Dvora and Koffas 2013). However, in some bacteria and fungi there exists an 428 
alternative pathway where L-tyrosine is converted directly into p-coumaric acid via the action of tyrosine 429 
ammonia-lyase (TAL), hence bypassing the C4H step (Figure 6). As a first step towards establishing a 430 
platform strain for the production of polyphenols in L. lactis, in collaboration with Nielsen and coworkers, 431 
we identified several novel TAL enzymes that specifically produce high levels of p-coumaric acid from L-432 
tyrosine (Jendresen et al. 2015). 433 
To test the potential of L. lactis to produce more complex phenolic compounds, we introduced a pathway for 434 
the biosynthesis of resveratrol. The introduced pathway consisted of three enzymes: TAL, 4CL (4-435 
coumaroyl-CoA ligase, which converts p-coumaric acid to p-coumaroyl-CoA), and STS (stilbene synthase, 436 
which catalyzes the condensation of p-coumaroyl-CoA and three molecules of malonyl-CoA to yield trans-437 
resveratrol, Figure 6). The corresponding genes were placed on the high copy number vector pNZ8048 438 
under the control of the nisin-inducible promoter PnisA. This promoter is a part of a tightly-controlled 439 
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inducible gene expression system which is based on the auto-regulatory mechanism controlling the 440 
production of the bacteriocin nisin (Kuipers et al. 1993; Kuipers et al. 1998). The producer L. lactis strain 441 
contains a chromosomally-integrated two-component system NisRK allowing induction of its target 442 
promoters by addition of sub-inhibitory concentrations of the bacteriocin nisin to the exponentially-growing 443 
cell culture (Linares et al. 2010). Upon cultivation of the producer strain in a chemically defined medium, 444 
production of trans-resveratrol was detected in the order of several mg l-1. When TAL was replaced with a 445 
promiscuous PAL/TAL enzyme (MacDonald and D’Cunha 2007), additional production of small amounts of 446 
pinosylvin (trans-3,5-dihydroxystilbene) from L-phenylalanine was observed. Furthermore, production of 447 
methylated variants of trans-resveratrol was also achieved (unpublished results). Obtained titers for trans-448 
resveratrol are comparable to that obtained in an early work on trans-resveratrol production in both E. coli 449 
and yeast (Beekwilder et al. 2006; Choi et al. 2011). Current research efforts focus on improving the 450 
production efficiency through metabolic engineering of the central carbon metabolism for increased 451 
precursor supply. 452 
Anthocyanins (glycosylated anthocyanidins) are another group of phenolic phytochemicals. In addition to 453 
their antioxidant properties, anthocyanins are valuable for their colors, which range from orange to blue 454 
(Falcone Ferreyra et al. 2012). They are of particular interest for the food industry as natural alternatives to 455 
replace synthetic dyes. Anthocyanins are synthesized from flavanones by ﬂavanone 3-hydroxylase (F3H), 456 
which adds a hydroxyl group to the C3 position. Resulting dihydroflavonols are further processed by 457 
dihydroflavonol 4-reductase (DFR), which catalyzes reduction of the carbonyl group of the C4 position to 458 
form leucoanthocyanidins, which in turn are converted to anthocyanidins via the action of anthocyanidin 459 
synthase (ANS). Anthocyanidins are further stabilized through a C3-glycosylation reaction usually catalyzed 460 
by UDP-glucose:flavonoid 3-O-glucosyltransferase (UFGT) to form the anthocyanidin 3-O-glucosides 461 
(Falcone Ferreyra et al. 2012) (Figure 6).  462 
In order to reconstruct the anthocyanin production pathway in L. lactis, native genes and genes codon-463 
optimized for L. lactis from various plant species coding for F3H, DFR, ANS and UFGT were placed under 464 
control of the nisin-inducible promoter PnisA on a high copy-number vector or were integrated into the 465 
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chromosome of L. lactis. Each protein was taggedg with an N- or C- terminal strep-tag, and Western blots 466 
were performed to detect the heterologous proteins in cell-free extract of L. lactis. Activity of each enzyme 467 
was probed in vitro and in vivo and the reaction products were analyzed using high performance liquid 468 
chromatography (HPLC). Production of various types of cyanidin-derived anthocyanidins and anthocyanins 469 
by the engineered L. lactis strains was detected, further demonstrating the potential of this lactic acid 470 
bacterium as a production host for plant-derived bioactive compounds for food applications (unpublished 471 
results). To our knowledge, this is the first report of using lactic acid bacteria for the production of complex 472 
phenolic compounds. 473 
Malonyl-CoA is a rate-limiting precursor in the biosynthesis of various phenolic compounds in bacteria (Xu 474 
et al. 2011; Bhan et al. 2013). Under physiological conditions, L. lactis cells use malonyl-CoA as a substrate 475 
in the chain elongation step of the fatty acid biosynthesis. FapR of Bacillus subtilis is a transcriptional 476 
repressor that directly senses the intracellular pool of malonyl-CoA. A metabolic biosensor based on the 477 
interaction of malonyl-CoA with FapR was previously designed in Escherichia coli (Xu et al. 2013). As a 478 
part of the efforts to enhance polyphenol production, a transcriptional biosensor for malonyl-CoA was 479 
constructed for the use in C. glutamicum but also proved to be fully functional  in L. lactis and could 480 
therefore be used for screening of variants with an enhanced malonyl-CoA pool. 481 
Among other activities that were pursued in the early stages of the project, we also tried to express plant 482 
CYPs in L. lactis, as many steps of the polyphenol biosynthetic pathway are catalyzed by these heme-bound 483 
monooxygenases. Functional expression of genes encoding membrane-anchored CYPs in prokaryotes is 484 
known to be notoriously difficult, and is limited by problems associated with the differences in intracellular 485 
localization (natively to the plant endoplasmatic reticulum), membrane composition, protein folding, and 486 
cofactor utilization. The latter element became especially crucial when attempting to express these proteins 487 
in L. lactis, because this, normally anaerobic, bacterium does not have the ability to synthetize heme, despite 488 
undergoing a metabolic shift to respiration when supplemented with an exogenous source of heme and being 489 
capable of regulating heme homeostasis (Pedersen et al. 2012). 490 
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We focused our efforts on CYP79A1 from Sorghum bicolor as it is a well-characterized CYP involved in 491 
dhurrin biosynthesis (Bak et al. 2000), and has been previously successfully produced in E. coli (Vazquez-492 
Albacete et al. 2016). As a testbed for the expression of this CYP we have used the Waldo platform (Waldo 493 
et al. 1999) that was previously instrumental in producing functional CYP79A1 in E. coli. Briefly, the 494 
platform is based on a fusion of the membrane protein with a GFP folding reporter at the C terminus: the 495 
fused GFP is designed to act as a fluorescent reporter only when the membrane protein is properly folded 496 
and its C terminus is oriented towards the cytoplasm. 497 
We detected CYP79A1-GFP by both fluorescence measurements of the L. lactis culture and in-fluorescence 498 
protein gels, but were not able to detect activity of the CYP in our in vitro tests. Purified membrane protein 499 
fractions from cell cultures grown both aerobically (with hemin supplementation) and anaerobically (with 500 
addition of hemin after purification of membrane proteins) did not show any product formation in our TLC-501 
based assay (Blomstedt et al. 2012). These results suggested that CYP79A1 was probably misfolded in L. 502 
lactis, although we did not perform any follow-up experiments to confirm this hypothesis. The topic was not 503 
pursued any further because any CYP active in the biosynthetic pathways for the selected model compounds 504 
could be by-passed (for example the C4H-catalyzed step could be by-passed by using TAL instead of PAL). 505 
Corynebacterium glutamicum 506 
C. glutamicum is an important organism in industrial biotechnology for the microbial production of bulk 507 
chemicals, in particular of amino acids (Becker and Wittmann 2012). C. glutamicum is a very robust 508 
microorganism, which shows high resistance to the presence of small aromatic compounds (Liu et al. 2013), 509 
which renders C. glutamicum a very promising host for the production of pharmacologically interesting 510 
plant-derived polyphenols (Marienhagen and Bott 2013). Until recently, the activity of a complex catabolic 511 
network for aromatic compounds meant that C. glutamicum was not used for the production of aromatic 512 
compounds (except for aromatic amino acids) (Shen et al. 2012) due to rapid degradation of the products of 513 
interest. However, C. glutamicum can be easily modified genetically and a toolbox for the high-level 514 
expression of heterologous genes originating from other organisms, has become available, and is based on a 515 
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set of strong and inducible promoters (Eggeling and Bott 2005; Pátek and Nešvera 2013; Kortmann et al. 516 
2015).  517 
Surprisingly, in initial experiments, it turned out that C. glutamicum is able to grow on naturally occurring 518 
phenylpropanoids such as p-coumaric acid, ferulic acid, caffeic acid and 3-(4-hydroxyphenyl)-propionic acid 519 
as sole carbon and energy sources. The maximum growth rates on the selected phenylpropanoids ranged 520 
from 0.15 to 0.23 h-1 corresponding to doubling times of 3 to 4.5 hours (Kallscheuer et al. 2016a). We 521 
suspected that the activity of this pathway would come into conflict with any attempt to produce polyphenols 522 
as both pathways compete for phenylpropanoids. Unfortunately, the underlying metabolic pathway 523 
responsible for the degradation of phenylpropanoids in C. glutamicum was unknown at the start of the 524 
BacHBerry project. Global gene expression analyses were conducted, which led to the identification of a 525 
gene cluster consisting of seven genes (designated phdT, phdA, phdR, phdB, phdC, phdD and phdE). In 526 
response to feeding of the above-mentioned phenylpropanoids these genes were upregulated up to 100-fold 527 
(Kallscheuer et al. 2016a). In subsequent studies, it turned out that the genes in this cluster code for the 528 
enzymes of the phenylpropanoid catabolic pathway in C. glutamicum. The gene phdT codes for a 529 
phenylpropanoid transporter protein, whereas phdA and the predicted operon phdBCDE code for enzymes 530 
involved in the degradation of phenylpropanoids. The phd gene cluster is transcriptionally controlled by a 531 
MarR-type repressor encoded by phdR. Cultivation experiments conducted with C. glutamicum strains 532 
carrying single-gene deletions showed that loss of phdA, phdB, phdC or phdE abolished growth of C. 533 
glutamicum with all tested phenylpropanoid substrates. The intracellular accumulation of pathway 534 
intermediates determined via LC-ESI-MS/MS in single-gene deletion mutants showed that the phd gene 535 
cluster encodes for enzymes involved in a CoA-dependent, β-oxidative deacetylation pathway, which is 536 
essential for the utilization of phenylpropanoids in C. glutamicum. The identified pathway thereby represents 537 
a peripheral catabolic route responsible for chain shortening of phenylpropanoids to benzoic acids and 538 
acetyl-CoA (Figure 7). C. glutamicum converts the resulting intermediates benzoate, 4-hydroxybenzoate and 539 
protocatechuate to succinyl-CoA and acetyl-CoA by central degradation pathways for aromatic compounds 540 
(especially the well-characterized β-ketoadipate pathway), and catabolites are ultimately channeled into the 541 
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tricarboxylic acid cycle (Shen and Liu 2005) (Figure 7). Unexpectedly, C. glutamicum failed to grow on the 542 
phenylpropanoid, cinnamic acid, which lacks ring para-hydroxylation. Astonishingly, a C. glutamicum strain 543 
with a single deletion of the gene phdR coding for the identified transcriptional repressor was able to grow 544 
with cinnamic acid as sole carbon and energy source (Kallscheuer et al. 2016a). This indicated that PhdR has 545 
a pronounced specificity for hydroxylated phenylpropanoids, especially when hydroxylated in para-position 546 
of the aromatic ring. In the course of our studies, cinnamic acid was the only phenylpropanoid tested lacking 547 
this hydroxylation, so the complete specificity of this catabolic pathway of phenolics in C. glutamicum 548 
remains unknown. 549 
During construction of the C. glutamicum platform strain for plant polyphenol production, four gene clusters, 550 
comprising 21 genes, including four genes of the phd cluster involved in the catabolism of aromatic 551 
compounds, were deleted. The resulting platform strain C. glutamicum DelAro4 was unable to degrade any 552 
phenylpropanoid tested, and also could not utilize simple benzoic acids such as protocatechuate (Kallscheuer 553 
et al. 2016c). This strain was used as a chassis for the microbial production of polyphenols in particular, 554 
stilbenes and (2S)-flavanones, in C. glutamicum. 555 
Plasmid-borne expression of codon-optimized genes coding for a 4CL from parsley (Petroselinum crispum), 556 
a chalcone synthase (CHS) and a chalcone isomerase (CHI) from Petunia x hybrida from the strong T7 557 
promoter in this strain background enabled production of (2S)-flavanones (Figure 7). Maximal titers of 35 558 
mg l-1 naringenin and 37 mg l-1 eriodictyol were obtained from the supplemented phenylpropanoids p-559 
coumaric acid and caffeic acid, respectively. Expression of the 4cl gene in combination with a codon-560 
optimized gene coding for an STS from peanut (Arachis hypogaea) allowed for the production of the 561 
stilbenes pinosylvin, trans-resveratrol and piceatannol starting from supplemented phenylpropanoids 562 
cinnamic acid, p-coumaric acid and caffeic acid, respectively (Kallscheuer et al. 2016c) (Figure 7). Stilbene 563 
concentrations of up to 158 mg l-1 could be achieved in defined CGXII medium with 4% glucose and 564 
supplemented with cerulenin, a fatty-acid biosynthesis inhibitor that is known to enhance polyphenol 565 
production in bacteria by increasing the intracellular concentrations of malonyl-CoA (Santos et al. 2011; van 566 
Summeren-Wesenhagen and Marienhagen 2015; Cao et al. 2016). Engineering amino acid metabolism for an 567 
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optimal connection to the synthetic plant polyphenol pathways was conducted to enable stilbene production 568 
directly from glucose. Indeed, the additional heterologous expression of aroH from E. coli (coding for the 569 
first enzyme of the shikimate pathway responsible for the synthesis of aromatic amino acids) together with a 570 
codon-optimized gene coding for a TAL from Flavobacterium johnsoniae led to the production of up to 60 571 
mg l-1 trans-resveratrol in the absence of supplemented p-coumaric acid (Kallscheuer et al. 2016c). 572 
Furthermore, C. glutamicum was used to produce trans-resveratrol from a cheaper precursor 4-573 
hydroxybenzoic acid (HBA) through reversal of a microbial β-oxidative phenylpropanoid degradation 574 
pathway (Kallscheuer et al. 2016b). This novel synthetic pathway circumvents any need for the endogenous 575 
supply of aromatic amino acids as polyphenol precursors and in C. glutamicum instantly yielded 5 mg l-1 576 
trans-resveratrol from supplemented HBA without any further optimization. Very recently, we also 577 
engineered C. glutamicum to produce more complex polyphenols including flavonols (kaempferol and 578 
quercetin) and O-methylated stilbenes (pinostilbene and pterostilbene). The obtained pterostilbene titer was 579 
42 mg l-1, which is comparable to the titer of 50 mg l-1obtained in engineered E. coli. In C. glutamicum, for 580 
the flavonols kaempferol and quercetin titers of 23 mg l-1 and 10 mg l-1, respectively, were detected. The 581 
aforementioned titers were obtained from the phenylpropanoids p-coumaric acid and caffeic acid , 582 
respectively, as precursors and represent the highest flavonol titers obtained in engineered microorganism 583 
until today (Kallscheuer et al. 2017). 584 
The main bottlenecks for the production of polyphenols turned out to be the TAL activity as well as the 585 
intracellular availability of malonyl-CoA, representing the cosubstrate in the STS- and CHS-reactions. On-586 
going efforts to improve polyphenol production in C. glutamicum therefore focus mainly on improving the 587 
activity of the rate-limiting enzymes and increasing the intracellular malonyl-CoA pool. 588 
Other activities 589 
As a part of this work, we also aimed at reconstruction of a previously unknown biosynthetic pathway for the 590 
flavonol fisetin (3,7,3′,4′-tetrahydroxyflavone, Figure 8). Fisetin is a potent anti-inflammatory, anti-cancer, 591 
and anti-oxidant compound (Suh et al. 2008; Funakoshi-Tago et al. 2011; Jash and Mondal 2014). Moreover, 592 
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it has been demonstrated to have a neuroprotective effect and also to limit the complications of type I 593 
diabetes (Maher 2009; Maher et al. 2011). Based on the molecular structure of this compound, we 594 
hypothesized that its biosynthesis should follow the general pathway of flavonol biosynthesis (Figures 6 and 595 
8): a flavanone precursor would be converted into dihydroflavonol by F3H, and then further converted into 596 
the corresponding flavonol via the action of flavonol synthase (FLS). In the last step of the biosynthesis, a 597 
hydroxyl group would be added at the C3’ position by ﬂavonoid 3’-hydroxylase (F3’H). This part of the 598 
work was carried out in E. coli. Isoliquiritigenin (2',4',4-trihydroxychalcone) appeared to be the most suitable 599 
precursor, and when supplied to an E. coli culture expressing F3H and FLS from Arabidopsis thaliana, 600 
production of garbanzol and resokaempferol was detected.  Resokaempferol could be further converted into 601 
fisetin by expression of F3’H genes from A. thaliana and Pn. hybrida fused with a cytochrome-P450 602 
reductase (CPR) from Catharanthus roseus (Stahlhut et al. 2015). The three enzymes were then combined 603 
with the isoliquiritigenin biosynthetic pathway, consisting of TAL from Rhodobacter sphaeroides, 4CL from 604 
Pr. crispum, CHI from Medicago sativa, and a fusion protein of CHS from Pn. hybrida and CHR from 605 
Astragalus mongholicus, to yield 0.3 mg l-1 of fisetin (Stahlhut et al. 2015). This work allowed reconstruction 606 
of a complete pathway for the biosynthesis of fisetin from L-tyrosine as the starting precursor using enzymes 607 
from various sources, and the identified pathway is currently being transferred to Gram-positive hosts. 608 
Bioinformatics and modelling 609 
There were multiple activities within BacHBerry, both within the discovery and the microorganism 610 
engineering sectors, which required the use of bioinformatics tools. Hence, the mathematical modeling and 611 
computational parts of the project aimed at addressing three major problems. The first two were related to 612 
gene expression, either for performing functional genomics analysis using the RNA-seq data from berries or 613 
to design sequences for heterologous expression of plant genes in microbes. The third problem concerned 614 
metabolic network optimization for both a single population and for a community of microbes. We detail 615 
below the main results obtained on each of the above activities. Other subjects that were addressed as a part 616 
of this project were metabolic communication between the different species in a community (Milreu et al. 617 
2014; Andrade et al. 2016) and modeling dynamic metabolic networks for potential application in strain 618 
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optimization (Costa et al. 2014; Hartmann et al. 2015a; Hartmann et al. 2015b; Costa et al. 2016; Hartmann 619 
et al. 2016). 620 
Sequencing data analysis and plant functional genomics 621 
Understanding which genes are differentially expressed during phenolic production by plants requires the 622 
capacity to undertake a rapid analysis of RNA-seq data. One of the main problems to be addressed in this 623 
case is the search for coding sequences that are homologous to those already present in sequence databases, 624 
which involves identification, selection and annotation of the best matches. Currently, such analyses rely 625 
heavily on manual curation as well as on the manual assembly of results obtained using different 626 
computational procedures and sequence databases. Automated processes become crucial in the light of the 627 
ever-increasing amounts of generated transcriptome data. Furthermore, automation of processes also allows 628 
improvement of the quality of the analyses, as the likelihood of human error grows with the amount of 629 
manual processing and verifications necessary. Moreover, most of the existing tools are able to annotate the 630 
transcriptome but lack the curation functionalities that are as important as the primary homology-based 631 
identification of candidate genes.  632 
As mentioned previously we developed a pipeline called MassBlast (Veríssimo et al. submitted), to improve 633 
and accelerate the annotation procedure of RNA-seq data. Besides allowing for operators to query multiple 634 
databases for performing homology searches, the tool also provides a set of parameters that can be defined in 635 
a user-friendly way. MassBlast seeks the best alignment between the sequences in a dataset consisting of 636 
contigs obtained from RNA-seq assemblies and a database of known sequences. In the context of BacHBerry 637 
and as a general validation of the method, MassBlast was used for the analysis of the blackberry 638 
transcriptome, and preliminary results showed a significant improvement in annotation speed (five minutes 639 
versus at least 26 working days, to annotate all known CYP families in blackberry) with very high 640 
accuracies. MassBlast is freely available at https://github.com/averissimo/mass-blast/.  641 
Sequence design for heterologous expression 642 
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Synthetic biology aims at constructing microorganisms capable of producing economically-relevant 643 
chemical products in a cost-effective way, which involves optimizing the functioning of metabolic pathways 644 
and reactions. These pathways and reactions involve proteins that are frequently heterologous. In order to 645 
increase the production of metabolites, it is possible to optimize heterologous protein production in the target 646 
host. This may be done by altering the codons in the gene that encodes for that protein. Each codon is a 647 
sequence of three nucleotides encoding one amino acid that is part of a protein. Since each amino acid can be 648 
encoded by several synonymous codons, a given protein can be expressed using a large number of different 649 
codon combinations. 650 
To address this problem, we worked on improving the machine learning models capable of predicting protein 651 
expression levels based on their codon usage frequency (Fernandes et al. 2016) by using Support Vector 652 
Regression (SVR) and Partial Least Squares (PLS). SVR yields predictions that surpass those of PLS. It has 653 
been shown that it is possible to improve the predictive ability of the models by using two additional input 654 
features, namely codon identification number and codon count, besides the already used codon bias and 655 
minimum free energy. In addition, applying ensemble averaging to the SVR or the PLS model improved the 656 
results even further. Different ensembles and features can be tested with the aim of further improving the 657 
prediction models. 658 
Metabolic network optimization 659 
Another goal of the computational activities of BacHBerry was to explore methods for in silico metabolic 660 
engineering of phenolic production in L. lactis and C. glutamicum. For this we selected four model target 661 
compounds: fisetin, trans-resveratrol, pelargonidin and quercetin. Additionally, optimization of malonyl-662 
CoA production was also considered, since this is known to be a major bottleneck in heterologous flavonoid 663 
production.  The first step involved performing network optimization for a single population, which included 664 
prediction of knock-out strategies and determination of minimal sets of genetic interventions that could 665 
guarantee an increased production of the target compound production based on stoichiometric models for the 666 
two organisms. These predictions were compared with experimental results and model refinement was 667 
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conducted in cases of discrepancies. For the second step, we considered a use of microbial consortia for 668 
production purposes. A method was developed that is being used for modeling the production of the 669 
compounds of interest for BacHBerry using L. lactis and C. glutamicum. Other, possibly larger consortia, 670 
may be considered in the future. 671 
Single strain-based production 672 
Recently, several computational methods for in silico metabolic network optimization have emerged and are 673 
currently being applied in metabolic engineering (Vera et al. 2010; Zomorrodi et al. 2012; Machado et al. 674 
2015; Simeonidis and Price 2015; Bergdahl et al. 2015). They are based on different approaches and 675 
rationales, thereby leading to distinct solutions. One key issue is the multitude of results, known to be 676 
dependent on the specific algorithms and solvers, used. In order to address this problem, a consensus-based 677 
approach was developed, following our work on meta-analysis of transcriptomic studies (Caldas et al. 2014). 678 
This method is based on running several optimization procedures and analyzing a posteriori the solutions, 679 
looking for a consensus. The rationale is to have rankings of hypotheses that may provide confidence in 680 
particular sets of proposed genetic alterations from various aspects. 681 
In the case of a single population of microbes (i.e. a monoculture), the genome-scale models of L. lactis and 682 
C. glutamicum were extended with the biosynthetic pathways of the four above-mentioned target compounds 683 
(Figure 9). Subsequently, five different optimization methods were applied to the genome-scale models 684 
(extended with the heterologous pathways): OptKnock (Burgard et al. 2003),  MOMA (Segrè et al. 2002),  685 
OptGene (Patil et al. 2005),  RoboKod (Stanford et al. 2015), and  RobustKnock (Tepper and Shlomi 2010), 686 
and the consensus ranking was obtained for each strain and compound. The hypotheses were generated with 687 
the rank product test and the outputs were lists of gene deletions that would achieve the best ranks using 688 
defined criteria, namely maximum predicted target compound production, maximizing the minimum 689 
predicted target compound production and distance from the wild-type flux distribution. These results were 690 
then further filtered and experimentally validated, resulting in several promising mutant strains where 691 
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production was increased by up to three-fold. Implementation of this pipeline is possible via a software 692 
package called OptPipe, available at https://github.com/AndrasHartmann/OptPipe. 693 
We then explored the concept of multi-objective optimization in the field of metabolic engineering when 694 
both continuous and integer decision variables were involved in the model. In particular, we proposed multi-695 
objective models to suggest reaction deletion strategies and to deal with problems where several functions 696 
must be optimized simultaneously, such as maximization of bioproducts while minimizing toxicity. We thus 697 
introduced Multi-Objective Mixed integer Optimization for metabolic engineering, a computational 698 
framework that aims to model and solve optimization problems, generated for predicting reaction knockout 699 
strategies by means of multi-objective programming. We compared the results from our method with those 700 
obtained by using the well-known bi-level optimization model (OptKnock). Furthermore, we studied two 701 
multi-objective optimization problems arising from the metabolic engineering of microorganisms, showing 702 
that indeed a multi-objective setting is promising, as it expands the set of generated hypotheses and allows 703 
inclusion of multiple goals, simultaneously. 704 
For a community of microbes 705 
Pure microbial cultures have long been used for production of high-value compounds, as illustrated by the 706 
example of S. cerevisiae producing artemisinic acid, an important precursor for the anti-malaria drug 707 
artemisinin, on a large scale (Ro et al. 2006; Lenihan et al. 2008). However, there is increasing evidence that 708 
such processes could run more efficiently if a community of microbial species is used (Logan and Rabaey 709 
2012; Jones et al. 2016; Wen et al. 2016). There are multiple reasons including an increased production 710 
efficiency of the system due to lessening of metabolic burden for individual cells. Another important 711 
consideration is that such community systems might have higher chances of avoiding toxic effects specific 712 
for individual microorganisms. Microbial consortia are believed to be able to sustain more complex 713 
production pathways, as well as being more robust as a group. The challenge, however, remains in 714 
establishing precisely which set of strains or species is best for the production of any given compound. 715 
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As part of BacHBerry, we introduced an initial topological model and a combinatorial algorithm that enabled 716 
us to propose optimal consortia to produce compounds that were either exogenous to the consortium, or were 717 
endogenous but where interaction between the species in the consortium could improve the production line 718 
(Julien-Laferrière et al. 2016). For initial validations of the model and the method, we applied it to two case-719 
studies taken from the literature. The first case involved production of two bioactive compounds, penicillin 720 
and cephalosporin C, both of which are antibiotics used in the pharma industry. A synthetic consortium 721 
composed of four different species, three Actinobacteria (Streptomyces cattleya, Rhodococcus jostii RAH_1 722 
and Rc. erythropolis BG43) and one methanogenic Archaea (Methanosarcina barkeri), was then run through 723 
the algorithm, allowing introduction of genetic manipulations and regulatory processes. We showed that the 724 
best solution involved only two of the four species, namely St. cattleya and M. barkeri (Julien-Laferrière et 725 
al. 2016).Another considered case was a consortium that may be seen as artificial in the sense that it 726 
associates two wild-type populations of microbes, pathogenic γ-proteobacteria Klebsiella pneumoniae and 727 
methanogenic Archaea M. mazei, which normally do not interact in nature. K. pneumoniae is a natural 728 
producer of 1,3-propanediol, which is an important building block for polymer production. Our results 729 
demonstrated that co-cultivation of K. pneumoniae with M. mazei may enable obtaining higher yields of this 730 
compound in Klebsiella (Julien-Laferrière et al. 2016). This supported a previous study  involving co-731 
cultures of Clostridium sp. with methanogenes such as Methanosarcina sp. CHTI55 (Koesnandar et al. 732 
1990). The developed algorithms are currently being used for developing consortia of polyphenol-producing 733 
Gram-positive bacteria. This task was inspired by the work of Jones and colleagues, who were able to 734 
achieve an overall 970-fold improvement in titers for flavan-3-ols production from phenylpropanoic acids by 735 
using a co-culture of two E. coli strains with further optimization of cultivation conditions, as compared to 736 
previous studies that used monocoltures for this purpose (Jones et al. 2016). 737 
Recovery and purification of polyphenols from fermentation broth 738 
Downstream processing is an important part of any production process and consists of steps required for 739 
recovery and purification of biosynthetic products from fermentation broth, which may have a significant 740 
impact on the final costs of a product (Goldberg 1997). In the design of downstream processing within 741 
31 
 
BacHBerry, trans-resveratrol (Figure 7) was used as the test product, being one of the model phenolic 742 
compounds that was successfully produced in both C. glutamicum and L. lactis.  743 
In a typical fermentation broth, most of the components present are either hydrophilic (e.g., salts, organic 744 
acids, non-consumed carbon sources (usually glucose), nitrogen source (ammonium sulfate, for instance)) or 745 
are much larger molecules than trans-resveratrol (e.g., proteins, nucleic acids, cells in suspension). This 746 
suggested a downstream processing design strategy that used either solubility and hydrophobicity as the 747 
driving forces, or alternatively – size exclusion. Since, at low concentrations (around 100 mg l-1), 748 
crystallization would involve high energy costs per kg of product recovered, this option was discarded. Two 749 
possible extraction techniques, namely liquid-liquid extraction and solid-liquid adsorption, were investigated 750 
as means of recovering and purifying extracellularly produced trans-resveratrol from a C. glutamicum 751 
fermentation broth containing spent CGXII medium and glucose, due to the higher production efficiency 752 
found in this bacterium. The downstream process design aimed at a recovery of at least 80% and a purity of 753 
95% trans-resveratrol. 754 
Liquid-liquid extraction is a technique to separate a given compound from a feed solution using an 755 
immiscible auxiliary phase that should be selective for that compound (Cox and Rydberg 2004). The 756 
logarithm (base 10) of the partition coefficient of trans-resveratrol between the aqueous and different 757 
potential organic phases was determined experimentally for several different solvents (Figure 10). The spent 758 
fermentation broth from C. glutamicum was used as the aqueous phase in these experiments. 759 
All tested organic solvents performed very well in extracting trans-resveratrol (minimum log P value is ~0.5, 760 
corresponding to a partition coefficient of 3.2), identifying them as suitable candidates for the recovery of 761 
this compound (when having different impurities present) (Figure 10). 762 
One of the drawbacks of using liquid-liquid extraction, however, is that it may interfere with protein folding 763 
and stability (Prince and Smith 2004). Besides measuring the partition of the polyphenols of interest in the 764 
aqueous and organic phases, the same analysis was performed for the total protein content. Although a 765 
considerable part of the total protein remained in the aqueous phase, some of the protein seemed to be 766 
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present in between the two liquid phases (probably as a result of denaturation and foaming) (Figure 11). 767 
This phenomenon might reduce the recovery of the desired phenolics, as it was also observed experimentally 768 
(data not shown). 769 
Solid-liquid adsorption using hydrophobic resins is another way of purifying trans-resveratrol. As in liquid-770 
liquid extraction, the high hydrophobicity of trans-resveratrol can be used to recover it selectively from the 771 
fermentation broth, leaving the more hydrophilic impurities behind. After an initial resin screen, one of the 772 
resins selected was the polystyrene-divinylbenzene based Amberlite XAD-16 from Sigma-Aldrich (particle 773 
diameter: 250-841 µm; dipole moment: 0.3; surface area: 900 m2 g-1; pore diameter: 100 Å).  774 
To test the ability of this resin to recover trans-resveratrol from C. glutamicum fermentation broth 775 
(containing CGXII spent medium and glucose), a lab-scale experiment was performed with an AKTA 776 
Explorer chromatographic workstation (GE Healthcare, Sweden) (see Figure 12). A 30 ml column was 777 
packed with resin and pre-equilibrated with MilliQ water. Afterwards, 10 ml of sample was injected and a 778 
washing step with pure water was performed for 10 column volumes (CV). During elution, a gradient of 779 
water/ethanol was run for about 12 CV and the peak of trans-resveratrol showed up at around 18 CV, at an 780 
ethanol percentage of 50% (v/v). Regeneration was performed with 100% ethanol. 781 
More hydrophilic molecules such as organic acids, sugars and salts appeared in the flow-through (the first 10 782 
CV). During the water/ethanol gradient, molecules desorbed as a function of their hydrophobicity. More 783 
hydrophobic molecules, such as trans-resveratrol, are supposed to elute at higher ethanol content in the 784 
mobile phase. In this case, trans-resveratrol appeared to be the compound eluting between 16 and 20 CV, 785 
since it also showed absorption at 304 nm (Camont et al. 2009). 786 
Although both liquid-liquid extraction and solid-liquid adsorption present their own advantages and 787 
disadvantages, a strong point for using adsorption is the use of ethanol instead of any other organic solvent 788 
that might not be regarded as GRAS. Moreover, not using liquid-liquid extraction avoids any possible 789 
problems related with protein precipitation and emulsification. The ethanol used during elution in adsorption 790 
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needs to be recovered from water by distillation (the azeotrope poses no problem as 80% (v/v) ethanol can be 791 
used). 792 
The proposed downstream process started with a solid-liquid separation step by centrifugation to separate 793 
biomass from the liquid broth. The clarified liquid phase was then sent continuously to one of two adsorption 794 
columns, operating staggered in time. The fraction rich in trans-resveratrol was subsequently evaporated, 795 
resulting in a wet slurry containing the polyphenol in the solid phase. This slurry was filtered in a rotary 796 
vacuum filter and washed with water to remove remaining impurities adhered to the surface of the crystals. 797 
The final step was a drying step to obtain the product in its final solid form. All the outlet streams containing 798 
ethanol were directed to a distillation column in order to recover the solvent. A make-up stream ethanol was 799 
added to compensate for losses. 800 
Optimization of phenolic production by fermentation and scale-up of bioprocesses 801 
There are multiple differences between microbial cultivation in shake flasks versus in bioreactors. The 802 
former lacks monitoring and control of various parameters, such as dissolved O2 concentration and pH (Zelle 803 
et al. 2010). Furthermore, the fed-batch fermentation mode, where one or more nutrient is being supplied 804 
throughout cultivation (Moulton 2014), can be done in a controllable and reproducible fashion only in 805 
bioreactors. These properties make bioreactors a suitable stage for optimization of cultivation conditions, 806 
often leading to significant improvements in production yields (Hujanen et al. 2001; Ratnam et al. 2003; Li 807 
et al. 2010; Rani and Appaiah 2011). 808 
From the beginning of the project it was clear that optimization of fermenter operation would need to be 809 
carried out using a model compound, because any newly-identified compounds would only be available at 810 
the end of the project. Hence this section of the project was focused on optimization of production of the 811 
model compound trans-resveratrol. However, it was expected that the strategies defined and the conclusions 812 
extracted from these results on trans-resveratrol will be valid for the optimization of the fermentation 813 
processes for the production of other target compound. Several L. lactis and C. glutamicum strains designed 814 
within the project were evaluated and used for fermenter process optimization. The experiments were carried 815 
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out in agitated 2 to 5 litre fermenters with automatically controlled pH, dissolved oxygen and temperature. 816 
Whenever required, oxygen was transferred to the medium by air injection at the bottom of the vessel. 817 
A major goal of the project was the development of an economically feasible and sustainable industrial 818 
process, therefore the following key optimization criteria were defined: (a) minimisation of the operation and 819 
investment cost and (b) maximisation of the production rate and operation yield. To achieve these 820 
optimization goals, the following variables have been investigated: (i) fermentation medium composition, (ii) 821 
dissolved oxygen concentration, (iii) operation strategy (batch vs. fed-batch and integrated vs. separate 822 
downstream operation). Our experiments suggested that there were several constraints limiting the operation 823 
strategy to be implemented, namely: cell metabolism, the stability of trans-resveratrol inside the fermenter, 824 
and the affinity of trans-resveratrol for the adsorption medium and solvents compared to other compounds 825 
present in the fermentation broth. 826 
Medium composition is an important parameter that often has a significant contribution towards the final 827 
production costs. According to our initial experiments, supplementation of C. glutamicum minimal medium 828 
with Brain-Heart Infusion (BHI) and a fatty-acid biosynthesis inhibitor, cerulenin, had a strong positive 829 
effect on the final titers of trans-resveratrol. However, removing these two components from the medium 830 
reduced medium costs by approximately 300-fold, resulting in a more than 50-fold drop in production costs 831 
(267 €/g compared to 5 €/g of trans-resveratrol without supplementation of BHI and cerulenin). 832 
We also evaluated the feasibility of producing phenolic compounds from waste materials, namely cheese 833 
whey using L. lactis as a host. Whey is a lactose-rich dairy industry by-product with a high environmental 834 
impact, if dumped untreated (Palmieri et al. 2017). To achieve this task, our production strain was modified 835 
to allow it to grow and produce trans-resveratrol from lactose by introducing a plasmid carrying the lac 836 
operon (Maeda and Gasson 1986). Production at 2 litre-scale was tested using lactose as carbon source and 837 
comparing the productivity between the cultures with glucose or lactose. These experiments demonstrated 838 
that the production of trans-resveratrol from lactose, and therefore from whey, is possible with slightly 839 
inferior productivity compared to glucose. However, if whey is chosen as the fermentation medium, other, 840 
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more important, issues arise. The cost of whey is comparable to the cost of glucose but the cost of the 841 
fermentation medium is only a small part of the total production costs, so variables such as whey availability 842 
and quality, as well as the stability of supply and collecting logistics will determine the feasibility of the 843 
operation more than the small losses in productivity. Clearly, if a phenolic production industrial unit were to 844 
be implemented inside a dairy company with excess whey, the whey might then be the best raw material. 845 
Another parameter investigated was the influence of dissolved oxygen concentration on the production 846 
efficiency of L. lactis. This bacterium can activate its respiratory chain in the presence of hemin in the 847 
culture medium, and this has been demonstrated to enhance its survival allowing it to grow to higher cell 848 
densities (Duwat et al. 2001). Therefore the production strain efficiency was tested under the following 849 
conditions: aerobic with hemin added to the fermentation broth, aerobic without hemin, semi-aerobic, and 850 
fully anaerobic. In line with the available data, there was a significant increase in the final biomass when the 851 
strain was grown under aerobic conditions with hemin. However, the opposite was observed for the 852 
production of trans-resveratrol where the highest amounts of the compound were detected under anaerobic 853 
conditions. 854 
Lastly, we have also worked on establishing a system for continuous product removal from the fermentation 855 
broth in order to simplify downstream processing and reduce trans-resveratrol oxidation due to prolonged 856 
incubation. Two strategies for continuous adsorption and storage of secreted trans-resveratrol in a resin have 857 
been devised and tested: (i) “in situ” product removal that consisted of adding a resin directly to the 858 
fermentation broth and (ii) “continuous product removal” (ConPR) that involved constant pumping of the 859 
fermentation broth through a column filled with the adsorption resin. The supernatant was separated from 860 
cells via a tangential flow micro-filtration device, sent though the column, and then returned back into the 861 
fermenter (Figure 13). 862 
The obtained results demonstrated that both the “in situ” and ConPR strategies lowered the trans-resveratrol 863 
productivity, probably due to co-adsorption of p-coumaric acid, the precursor for trans-resveratrol. This 864 
effect was most pronounced in the “in situ” operation mode due to continuous contact of the resin with the 865 
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supernatant and cells. In the ConPR operation mode the effect was reduced due to low supernatant flow rate 866 
through the resin, however adsorption of trans-resveratrol was also reduced. In contrast, in the “in situ” 867 
mode the amount of adsorbed end-product was nearly identical to the amount of extracellular and 868 
intracellular trans-resveratrol produced in control experiments without addition of resin. Although the two 869 
techniques did not increase the overall productivity, they still simplified the downstream processing and may 870 
lead to a production cost reduction by eliminating the need to break down the cells. However, future research 871 
may provide a solution to avoid precursor co-adsorption resulting in increased polyphenol productivity. 872 
Dissemination, training, societal and ethical issues 873 
In addition to applying the latest technological advances from life sciences for establishing a pipeline for 874 
microbial-based polyphenol production, BacHBerry analyzed the economic potential of the possible products 875 
developed from this research. The assessment of economic issues of the project has been focused on the 876 
market potential of the natural colorants identified during the screening of the germplasm collection. This 877 
was done along with obtaining an overview of the relevant regulations and procedures for approval of novel 878 
food additives, including colorants, in the EU, the United States (US), and China. Regulations within both 879 
the EU and China confer a strict set of rules for bringing a novel food colorant, even a natural one, to the 880 
market. These rules consider not only the composition and purity of the substance, but also the process 881 
through which the compounds have been produced. In contrast, in the US, a new food additive can gain 882 
access to the market by simply passing the GRAS assessment. Hence, if a novel polyphenolic colorant could 883 
be produced using engineered microbial cell factories, the US market should probably be the first market to 884 
be targeted, owing to less strict regulatory requirements for the approval. 885 
Another topic addressed in BacHBerry was access and benefit sharing of genetic resources. As the project 886 
was built upon screening of berry species from multiple countries, including China, Russia, Chile, Portugal, 887 
and the UK, it is important to harness these resources in a responsible manner. The Nagoya Protocol on 888 
Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization 889 
(NP-ABS) is an agreement consisting of a set of rules for fair sharing of monetary and non-monetary benefits 890 
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arising from the usage and commercialization of genetic resources and traditional knowledge associated with 891 
those. It aims at achieving fairness and equity of gain distribution, especially towards indigenous and local 892 
communities (SCBD 2011; Morgera et al. 2014). The Protocol came into force in the EU as of November 893 
20th 2016. As most of the BacHBerry project partners were from EU Member States, we began collecting 894 
information about the best practices suggested from both the Convention on Biological Diversity (CBD) and 895 
the EU, and kept monitoring the relevant guidelines and updates from the EU on implementing ABS. Among 896 
the home countries of the project partners China, Denmark, France, Germany, Switzerland, and UK ratified 897 
or accepted the NP-ABS (as of November 2016) and began implementing the aforementioned regulations 898 
(European Parlament 2014). The UK also made its own regulation on implementing the Protocol (European 899 
Parlament 2014; NMRO (UK) 2015; Secretary of State (UK) 2015). 900 
Funded under the theme of “Knowledge-based Bio-Economy”, a final aim of the project was to provide 901 
scientific and technical solutions to harness berry resources, as well as to contribute to sustainable 902 
development of the economy. We consequently investigated the possible contributions of our research to 903 
build a more sustainable society based on environmental, economical, and social impacts (Pei and Schmidt 904 
2016). Furthermore, we conducted several open dialog events, namely workshops and interviews with 905 
potential stakeholders from Austria, Denmark, and China. One of the surprising outcomes was that the 906 
general public raised concerns over the use of genetically-modified organisms (GMOs) in the pipeline a lot 907 
less frequently than originally expected. A free, science-based game for mobile devices called “Berry 908 
Maker” was produced (http://www.berrymaker.com).  The game allows the user to follow the pipeline 909 
designed within our project, from acquisition of diverse berries, to extraction and analysis of biosynthetic 910 
genes, to microbial fermentation-based production of specific polyphenols and running a biotech factory that 911 
is exposed to real world situations, such as price fluctuations. The game is also available on iTunes1 and 912 
Google Play2 store. Lastly, a 22 minute documentary film was produced, showing sampling of berries, 913 
                                                          
1 See: https://itunes.apple.com/us/app/berrymaker-dna-soda-factory/id1163115116?ls=1&mt=8  
 
2 See: https://play.google.com/store/apps/details?id=com.biofaction.berrymaker 
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analysis of interesting compounds, and experiments with natural color pigments for food products from 914 
across Europe (see: https://vimeo.com/193467652). 915 
Conclusions 916 
During three years of the project, the BacHBerry partners successfully established a complete pipeline for 917 
screening, bioprospecting, identification, and microbial production of plant phenolic compounds in Gram-918 
positive bacteria. A summary of the most important results is presented in Table 5. The major highlights are 919 
construction of the extensive germplasm collection database, establishment of a method for high-throughput 920 
screening of bioactive extracts using the yeast-based human disease models, generation of a vast berry 921 
transcriptome database, construction of microbial cell factories in L. lactis and C. glutamicum for the 922 
production of polyphenols with yields comparable to those currently available from the literature, release of 923 
several software packages for transcriptome analysis and in silico-based metabolic engineering, as well as 924 
optimization of fermentation conditions and downstream processing for the selected organisms aimed at 925 
increasing the yield and the purify of the final products. The pipeline has been completely validated and is 926 
available to be picked up by the biotech industry for further improvement and commercialization. The 927 
developed methods and protocols should be suitable for discovery, as well as production of most groups of 928 
polyphenols in the above-mentioned organisms, without a need for significant alterations and adaptations. 929 
Overall, this project provided the scientific community with enabling tools and resources to further 930 
advancing research on berries, phenolic compounds, and metabolic engineering of microorganisms. 931 
Additional efforts were also focused on communication with stakeholders, public outreach, and 932 
popularization of science among the younger generation. The majority of the project outcomes is already 933 
available to the scientific community and the industry in form of peer-reviewed articles, or will be published 934 
within the coming year. 935 
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Figure legends 1411 
Figure 1: a) The molecular structure of the stilbene trans-resveratrol. b) Basic flavonoid structure. Rx are 1412 
positions where decorating groups (e.g. hydroxyl, acyl, glycosyl, etc.), which differentiate the compounds 1413 
and alter their chemical properties, could be attached. 1414 
Figure 2: Principal component analysis (PCA) plots of the full dataset without reference material and 1415 
blanks. Each dot represents the profile of one sample aliquot whereas lines delimit groups of samples that 1416 
cluster together. a) PCA plots of the full dataset without reference material and blanks in positive mode. 1417 
Components (Scr) 1 and 2 explain 9.79% and 7.59% of the variation respectively. b) PCA plots of the full 1418 
dataset without reference material and blanks in negative mode. Components (Scr) 1 and 2 explain 13.20% 1419 
and 10.30% of the variation respectively.  1420 
Figure 3: Schematic representation of yeast models. a. Yeast models of neurodegenerative diseases. 1421 
Humanized yeast strains encoding chimeric fusions of disease genes with GFP (green fluorescent protein) 1422 
under the control of a galactose-inducible (GAL1) promoter. Expression of Aβ42, αSyn (SNCA gene), FUS 1423 
and HTTpQ103 leads to the formation of toxic aggregates, recapitulating the pathological processes of 1424 
Alzheimer’s disease (AD), Parkinson’s disease (PD), Amyotrophic lateral sclerosis (ALS), and Huntington’s 1425 
disease (HD), respectively. b. Yeast model of Crz1 (NFAT orthologue) activation. Crz1 is activated by the 1426 
serine/threonine protein phosphatase calcineurin (composed by CnA and CnB subunits). The reporter strain 1427 
encodes the lacZ gene under the control of a promoter containing Crz1-binding sites, allowing the 1428 
assessment of Crz1 activation through the measurement of β-galactosidase activity. 1429 
Figure 4: Identification of bioactivities in the berry germplasm. a) Strategy used for the discovery of 1430 
bioactive compounds for Alzheimer’s disease. BY4741_erg6 recombinant yeast cells expressing GFP-Aβ42 1431 
were grown in SD galactose medium and cell viability was assessed by growth curves for 24 h in cells 1432 
challenged or unchallenged with Lycium chinense polyphenol extracts. Cells containing the empty vector 1433 
were used as controls. The areas under the curve (AUC) were integrated using the Origin software 1434 
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(OriginLab, Northampton, MA). Values represent the mean ± standard error of mean (SEM) of at least three 1435 
biological replicates.  1436 
b) Strategy used for the discovery of bioactive compounds with anti-inflammatory potential. BY4741 yeast 1437 
cells encoding CDREpromoter-lacZ were treated or not with Lycium chinense polyphenol extracts and induced 1438 
with 1.8 mM MnCl2. Crz1 activation was assessed by monitoring β-galactosidase activity using ortho-1439 
nitrophenyl-β-galactoside (ONPG). The immunosuppressant FK506, a well-known inhibitor of calcineurin 1440 
(Dumont 2000) was used as a positive control. The values represent the mean ± SEM of at least three 1441 
biological replicates, *p < 0.05, **p < 0.01, ***p < 0.001. 1442 
Figure 5. Yeast as a discovery platform of therapeutic compounds. Iterative bio-guided fractionation of 1443 
complex mixtures allows the discovery of small molecules improving cell growth, by rescue of protein 1444 
aggregates toxicity, or inhibiting inflammatory processes. High-throughput formats aligned with chemical 1445 
identification by LC-MS approaches accelerate the identification of candidate compounds. 1446 
Figure 6: Polyphenol biosynthetic pathway in plants (modified from Falcone Ferreyra et al. 2012). PAL, 1447 
phenylalanine ammonia-lyase; C4H, cinnamate 4-hydroxylase; 4CL, 4-coumaroyl-CoA ligase; CHS, 1448 
chalcone synthase; CHI, chalcone isomerase; F3H, ﬂavanone 3-hydroxylase; F3’5’H, ﬂavonoid 3’-5’-1449 
hydroxylase; DFR, dihydroﬂavonol 4-reductase; ANS, anthocyanidin synthase; ANR, anthocyanidin 1450 
reductase; UFGT, flavonoid 3-O-glucosyltransferase. LAR, leucoanthocyanidin reductase; FNS, flavone 1451 
synthase; FLS, flavonol synthase; STS, stilbene synthase. P450 enzymes are highlighted in red. 1452 
Figure 7: Overview of the endogenous phenylpropanoid degradation and the engineered pathway for 1453 
polyphenol synthesis in C. glutamicum. One of the precursors for the production of the stilbene trans-1454 
resveratrol (catalyzed by stilbene synthase, STS) or for naringenin chalcone (catalyzed by chalcone 1455 
synthases, CHS) is p-coumaroyl-CoA. Naringenin chalcone isomerizes to the (2S)-flavanone naringenin 1456 
either spontaneously or catalyzed by the activity of chalcone isomerase (CHI). In C. glutamicum, p-coumaric 1457 
acid can be degraded to 4-hydroxybenzoate by a CoA-dependent, β-oxidative deacetylation pathway. 4-1458 
Hydroxybenzoate is subsequently hydroxylated to protocatechuate, which is catabolized to succinyl-CoA 1459 
63 
 
and acetyl-CoA by the β-ketoadipate pathway. Genes coding for the underlined enzymes were deleted in the 1460 
course of the construction of the platform strain C. glutamicum DelAro4. 1461 
Figure 8: Heterologous biosynthetic pathway for fisetin assembled in E. coli. TAL, tyrosine ammonia-lyase; 1462 
4CL, 4-coumaroyl-CoA ligase; CHS::CHR, chalcone synthase::chalcone reductase fusion; CHI, chalcone 1463 
isomerase; F3H, ﬂavanone 3-hydroxylase; FLS, flavonol synthase; F3’H::CPR, ﬂavonoid 3’-1464 
hydroxylase::cytochrome P450 reductase fusion. 1465 
Figure 9: Heterologous biosynthetic pathways introduced into the genome-scale models of C. glutamicum 1466 
and L. lactis leading to the four target compounds: i) trans-resveratrol ii) pelargonidin iii) quercetin and iv) 1467 
fisetin. Two heterologous enzymes (TAL and 4CL) are common for the biosynthesis of the phenolic 1468 
molecules. Enzyme abbreviations: TAL, tyrosine ammonia-lyase; 4CL, 4-coumaroyl-CoA ligase; STS, 1469 
stilbene synthase; CHS, chalcone synthase; CHR, chalcone reductase; CHI, chalcone isomerase; F3H, 1470 
flavanone 3–hydroxylase; FLS, flavonol synthase; F3’H, flavonoid 3' hydroxylase; CPR, cytochrome P450 1471 
reductase. 1472 
Figure 10: Partition coefficients in the form of log P values of trans-resveratrol using different organic 1473 
solvents using C. glutamicum fermentation broth as the aqueous phase. 1474 
Figure 11: On the left, protein concentration (expressed as percentage of the initial broth protein 1475 
concentration) in the organic and aqueous phases, after performing liquid extraction. The concentration in 1476 
the organic phase is almost zero (considering the error bars), indicating that some protein stayed in the 1477 
interphase. On the right, the formation of an interphase after the broth had been extracted with organic 1478 
solvent (a mixture of heptanoic acid and hexyl acetate in this case) was clear. 1479 
Figure 12: Chromatogram following a pulse injection of 10 ml of C. glutamicum spent fermentation broth in 1480 
a 30 ml column packed with Amberlite XAD-16 resin. A washing step was performed with 10 column 1481 
volumes (CVs) of MilliQ water. Afterwards, elution was performed with a water/ethanol gradient for 12 CV, 1482 
followed by a final regeneration step with 100% ethanol.   1483 
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Figure 13: Experimental set-up for the “Continuous Product Removal” mode.  1484 
  1485 
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Tables 1486 
Table 1: Anthocyanidin structures (aglycone form) found in different berry species. The presence of a 1487 
compound is noted with + whereas the absence is noted with -.  1488 
Type Pelargonidin Cyanidin Delphinidin Peonidin Petunidin Malvinidin 
Structure 
      
Molecular 
formula 
C15H11O5+ C15H11O6+ C15H11O7+ C16H13O6+ C16H13O7+ C17H15O7+ 
Fragaria1 + + - - - - 
Ribes1 + + + - + - 
Rubus1 + + - - - - 
Vaccinium1 - + + + + + 
Vitis1 - + + + + + 
Lonicera2,5 + + + + - + 
Lycium3 - - + - + + 
Berberis4 - + + + + + 
Ugni4 - + - + - - 
Aristotelia6 - + + - - - 
1 Phenol explorer database (http://phenol-explorer.eu); 2 (Chaovanalikit et al. 2004); 3 (Zheng et al. 2011); 4  1489 
(Ruiz et al. 2010); 5  (Wang et al. 2016b); 6 (Fredes et al. 2014) 1490 
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Table 2: Selected species for bioactivity testing according to the phytochemical diversity. 1493 
Species Variety/line Species Variety/line 
Aristotelia chilensis 
(Molina)Stuntz 
- Rubus armeniacus Focke Himalayan Giant 
Berberis buxfolia Lam. - Rubus occidentalis L. Huron 
Lonicera caerulea L. S322-23 Rubus loganobaccus L.H.Bailey Sunberry 
Lycium chinense Mill. - Rubus loganobaccus L.H.Bailey Tayberry 
Ribes grossularia L. 9294 Rubus bartonii Newton Ashton Cross 
Ribes grossularoides Maxim. H1-12-1 Rubus fruticosus L. agg. Fantasia 
Ribes nevadense Kellog - Rubus brigantinus Samp. - 
Ribes spp. 644217 Rubus genevierii Boreau. - 
Ribes spp. 1126 Rubus henriquesii Samp. - 
Ribes spp. 2292-1 Rubus hochstetterorum Seub. - 
Ribes spp. Muravushka 
Rubus sampaioanus Sudre ex 
Samp. 
- 
Ribes spp. - Rubus vagabundus Samp. - 
Ribes petraeum Wulf. R2-1-2 Rubus idaeus L. Octavia 
Ribes x saundersii Jancz. XB4 Rubus idaeus L. Prestige 
Ribes bethmontii Jancz. XW6 Ugni molinae Turcz. Red Pearl 
Ribes rubrum L. S11-3-36 Vaccinium uliginosum L. - 
Rubus spp. B14 Vaccinium vitis-idaea L. - 
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Table 3: Transcriptome resources for berries developed on BacHBerry 1496 
Species Plant material Total number of raw reads 
Aristotelia sp. ripe berries 397,707,372 
Berberis sp. ripe berries 444,362,698 
Corema sp. leaf 353,604,932 
Lonicera sp. ripe berries 397,214,254 
Ribes sp.1 ripe berries 336,479,242 
Ribes sp.2 ripe berries 393,665,630 
Rubus sp.1 berries (3 stages) 1,040,224,680 
Rubus sp.2 berries (3 stages) 1,064,858,518 
Rubus sp.3 ripe berries 505,754,030 
Rubus sp.4 ripe berries 390,608,452 
Ugni sp. ripe berries 405,024,920 
Vaccinium sp.1 ripe berries 373,159,882 
Vaccinium sp.2 ripe berries 375,778,718 
 1497 
  1498 
68 
 
Table 4: Statistics on five major enzyme families representing conserved biochemical steps of the 1499 
phenylpropanoid pathway. Candidates displayed more than 70% sequence coverage to reference query 1500 
sequences. This work led to the creation of a large dataset of candidates used for pathway elucidation and 1501 
reconstitution in bacterial hosts. 1502 
Enzyme families Candidates per transcriptome (min-max) 
Conserved phenylpropanoid pathway enzymes 109-180 
CYPs 100-177 
UGTs 70-145 
2-OGDs 32-88 
O-methyltransferases 8-51 
Acyltransferases 23-36 
 1503 
  1504 
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Table 5: Summary of the outcomes of the project 1505 
Specific 
application 
area in 
project 
Bioprospecting for discovery of 
novel berry phenolics 
Characterization of phenolics 
biosynthetic pathways 
Bacterial cell factories for 
production of berry phenolics 
Fermentation and 
bioprocess engineering 
General aims 
of BacHBerry 
To tap into the biodiversity of berries 
from around the globe and of their 
phenolics content 
Identification and characterization 
of berry phenolics biosynthetic 
pathways 
Design and generation of bacterial 
cell factories for production of high-
value berry phenolics 
Implementation of production of high-
value phenolics in fermenters up to 
demonstration scale 
Achievements 
of the project 
• Standardization of methodologies 
for harvesting, extract preparation, 
phenolics content assessment and 
fractionation 
 
• Metabolomics data from berry 
species originating from UK, 
mainland Europe, Russia, Chile, and 
China was obtained and made 
available in form of an online 
database 
 
• Implementation of robust assays 
based on the SMART platform for 
discovery of bioactivity and 
functionality 
• Transcriptomes of 13 germplasms 
spanning eight genera, seven 
families and seven orders were 
generated and analyzed 
 
•New algorithms for functional 
genomics and improved 
computational methods for 
pathway identification were 
established 
 
• Over 4000 candidate genes for 
various biosynthetic steps, 
transport and regulation of 
polyphenol production were 
identified 
• L. lactis strains were engineered for 
stilbene (trans-resveratrol and 
pterostilbene) and anthocyanin 
production 
 
• Production of various stilbenes 
(trans-resveratrol, pinosylvin, and 
piceatannol), methylated stilbenes 
(pinostilbene and pterostilbene), 
flavanones (naringenin, pinocembrin, 
and eryodictiol), and flavonols 
(kaempferol and quercetin) was 
achieved in C. glutamicum with 
yields comparable to those obtained 
in the model organism E. coli. 
Production titers for the produced 
• Cultivation conditions for improved 
productivity were developed for both 
L. lactis and C. glutamicum through 
optimization of fermentation 
parameters (batch versus fed-batch 
operation, substrate and dissolved 
oxygen concentration, etc.) 
 
• Whey was evaluated as an alternative 
carbon source for polyphenol 
production in L lactis 
 
• Multiple bioseparation methods for 
extraction of produced polyphenols 
from fermentation broth were 
evaluated 
70 
 
 
• Obtained berry extracts were 
assayed for bioactivity against 
several human diseases, and 
additionally evaluated for other 
functional uses (eq. food additives, 
antimicrobials). Bioactivities against 
Alzheimer’s, Parkinson’s and 
Huntington’s diseases, Amyotrophic 
Lateral Sclerosis and inflammation 
were detected. 
 
• Several pure bioactive effector 
compounds were identified and 
validated 
 
• Biochemical activities of some of 
the gene candidates were tested, 
thus validating the predictions 
flavonols are the highest titers 
obtained in engineered 
microorganism until today 
 
• Polyphenol production was further 
improved by engineering enhanced 
precursor supply (eq. L-tyrosine, 
malonyl-CoA) via rational design, 
modeling-based prediction, and use 
of biosensors 
 
• Alternative biosynthetic routes were 
explored though engineering of 
trans-resveratrol production from 4-
hydroxybenzoic acid (HBA) in C. 
glutamicum 
 
• Computational models were 
developed allowing predicting a 
minimal set of modifications needed 
for improved polyphenol production 
in both a single-strain population and 
a consortium of two or more species 
 
• Two possible designs for a system for 
continuous product removal from the 
fermentation broth were implemented 
 
• Resveratrol production in C. 
glutamicum was scaled up from shake 
flask to 5 l fermenter to demonstration 
scale (250 l) 
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 Figure 1: a) The molecular structure of the stilbene trans-resveratrol. b) Basic flavonoid structure. Rx are 
positions where decorating groups (e.g. hydroxyl, acyl, glycosyl, etc.), which differentiate the compounds 
and alter their chemical properties, could be attached. 
  
Figures Click here to download Figure BacHBerry_Figures.docx 
 Figure 2: Principal component analysis (PCA) plots of the full dataset without reference material and 
blanks. Each dot represents the profile of one sample aliquot whereas lines delimit groups of samples that 
cluster together. a) PCA plots of the full dataset without reference material and blanks in positive mode. 
Components (Scr) 1 and 2 explain 9.79% and 7.59% of the variation respectively. b) PCA plots of the full 
dataset without reference material and blanks in negative mode. Components (Scr) 1 and 2 explain 13.20% 
and 10.30% of the variation respectively.  
  
 Figure 3: Schematic representation of yeast models. a. Yeast models of neurodegenerative diseases. 
Humanized yeast strains encoding chimeric fusions of disease genes with GFP (green fluorescent protein) 
under the control of a  galactose-inducible (GAL1) promoter. Expression of Aβ42, αSyn (SNCA gene), FUS 
and HTTpQ103 leads to the formation of toxic aggregates, recapitulating the pathological processes of 
Alzheimer’s disease (AD), Parkinson’s disease (PD), Amyotrophic lateral sclerosis (ALS), and Huntington’s 
disease (HD), respectively. b. Yeast model of Crz1 (NFAT orthologue) activation. Crz1 is activated by the 
serine/threonine protein phosphatase calcineurin (composed by CnA and CnB subunits). The reporter strain 
encodes the lacZ gene under the control of a promoter containing Crz1-binding sites, allowing the 
assessment of Crz1 activation through the measurement of β-galactosidase activity. 
 
 
  
Figure 4: Identification of bioactivities in the berry germplasm. a) Strategy used for the discovery of 
bioactive compounds for Alzheimer’s disease. BY4741_erg6 recombinant yeast cells expressing GFP-Aβ42 
were grown in SD galactose medium and cell viability was assessed by growth curves for 24 h in cells 
challenged or unchallenged with Lycium chinense polyphenol extracts. Cells containing the empty vector 
were used as controls. The areas under the curve (AUC) were integrated using the Origin software 
(OriginLab, Northampton, MA). Values represent the mean ± standard error of mean (SEM) of at least three 
biological replicates.  
b) Strategy used for the discovery of bioactive compounds with anti-inflammatory potential. BY4741 yeast 
cells encoding CDREpromoter-lacZ were treated or not with Lycium chinense polyphenol extracts and induced 
with 1.8 mM MnCl2. Crz1 activation was assessed by monitoring β-galactosidase activity using ortho-
nitrophenyl-β-galactoside (ONPG). The immunosuppressant FK506, a well-known inhibitor of calcineurin 
(Dumont 2000) was used as a positive control. The values represent the mean ± SEM of at least three 
biological replicates, *p < 0.05, **p < 0.01, ***p < 0.001.  
  
 Figure 5. Yeast as a discovery platform of therapeutic compounds. Iterative bio-guided fractionation of 
complex mixtures allows the discovery of small molecules improving cell growth, by rescue of protein 
aggregates toxicity, or inhibiting inflammatory processes. High-throughput formats aligned with chemical 
identification by LC-MS approaches accelerate the identification of candidate compounds. 
 
 Figure 6: Polyphenol biosynthetic pathway in plants (modified from Falcone Ferreyra et al. 2012). PAL, 
phenylalanine ammonia-lyase; C4H, cinnamate 4-hydroxylase; 4CL, 4-coumaroyl-CoA ligase; CHS, 
chalcone synthase; CHI, chalcone isomerase; F3H, ﬂavanone 3-hydroxylase; F3’5’H, ﬂavonoid 3’-5’-
hydroxylase; DFR, dihydroﬂavonol 4-reductase; ANS, anthocyanidin synthase; ANR, anthocyanidin 
reductase; UFGT, flavonoid 3-O-glucosyltransferase. LAR, leucoanthocyanidin reductase; FNS, flavone 
synthase; FLS, flavonol synthase; STS, stilbene synthase. P450 enzymes are highlighted. 
  
 Figure 7: Overview of the endogenous phenylpropanoid degradation and the engineered pathway for 
polyphenol synthesis in C. glutamicum. One of the precursors for the production of the stilbene trans-
resveratrol (catalyzed by stilbene synthase, STS) or for naringenin chalcone (catalyzed by chalcone 
synthases, CHS) is p-coumaroyl-CoA. Naringenin chalcone isomerizes to the (2S)-flavanone naringenin 
either spontaneously or catalyzed by the activity of chalcone isomerase (CHI). In C. glutamicum, p-coumaric 
acid can be degraded to 4-hydroxybenzoate by a CoA-dependent, β-oxidative deacetylation pathway. 4-
Hydroxybenzoate is subsequently hydroxylated to protocatechuate, which is catabolized to succinyl-CoA 
and acetyl-CoA by the β-ketoadipate pathway. Genes coding for the underlined enzymes were deleted in the 
course of the construction of the platform strain C. glutamicum DelAro4. 
 
 Figure 8: Heterologous biosynthetic pathway for fisetin assembled in E. coli. TAL, tyrosine ammonia-lyase; 
4CL, 4-coumaroyl-CoA ligase; CHS::CHR, chalcone synthase::chalcone reductase fusion; CHI, chalcone 
isomerase; F3H, ﬂavanone 3-hydroxylase; FLS, flavonol synthase; F3’H::CPR, ﬂavonoid 3’-
hydroxylase::cytochrome P450 reductase fusion. 
 
 Figure 9: Heterologous biosynthetic pathways introduced into the genome-scale models of C. glutamicum 
and L. lactis leading to the four target compounds: i) trans-resveratrol ii) pelargonidin iii) quercetin and iv) 
fisetin. Two heterologous enzymes (TAL and 4CL) are common for the biosynthesis of the phenolic 
molecules. Enzyme abbreviations: TAL, tyrosine ammonia-lyase; 4CL, 4-coumaroyl-CoA ligase; STS, 
stilbene synthase; CHS, chalcone synthase; CHR, chalcone reductase; CHI, chalcone isomerase; F3H, 
flavanone 3–hydroxylase; FLS, flavonol synthase; F3’H, flavonoid 3' hydroxylase; CPR, cytochrome P450 
reductase. 
 
 Figure 10: Partition coefficients in the form of log P values of trans-resveratrol using different organic 
solvents using C. glutamicum fermentation broth as the aqueous phase. 
  
 Figure 11: On the left, protein concentration (expressed as percentage of the initial broth protein 
concentration) in the organic and aqueous phases, after performing liquid extraction. The concentration in 
the organic phase is almost zero (considering the error bars), indicating that some protein stayed in the 
interphase. On the right, the formation of an interphase after the broth had been extracted with organic 
solvent (a mixture of heptanoic acid and hexyl acetate in this case) was clear. 
  
 Figure 12: Chromatogram following a pulse injection of 10 ml of C. glutamicum spent fermentation broth in 
a 30 ml column packed with Amberlite XAD-16 resin. A washing step was performed with 10 column 
volumes (CVs) of MilliQ water. Afterwards, elution was performed with a water/ethanol gradient for 12 CV, 
followed by a final regeneration step with 100% ethanol.   
  
 Figure 13: Experimental set-up for the “Continuous Product Removal” mode.  
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Table S1 – Decorating glycosyl groups of anthocyanins found in different berry species. The presence 
of a glycosylation pattern is noted with + whereas the absence is noted with -. 
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Fragaria1 + + - + - - - - - - - - - - 
Ribes1 - + + + + + - - + - + - - - 
Rubus1 - + - + - + + + + - + - - - 
Vaccinium1 + + + - - - - - - - - - - - 
Vitis1 - + - - - - - - - - - - - - 
Lonicera2 - + - + - - - + - - - - + - 
Lycium3 - - - - - - - + - - - + - + 
Berberis4,5 - + - + + - - + - + - - - + 
Ugni4 - + - - - - - - - - - - - - 
1 Phenol explorer database (http://phenol-explorer.eu) 
2 Chaovanalikit et al., 2004 
3 Zheng et al., 2011 
4 Ruiz et al., 2010 
5 Ruiz et al., 2013 
 
Table S2 – Decorating acyl groups of anthocyanins found in in a variety of berry species 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 Phenol explorer database (http://phenol-explorer.eu) 
2 Figueiredo-Gonzalez et al. 2012 
3 Zheng et al. 2011 
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Fragaria1 - + + - - - - 
Ribes1 - - - - + - + 
Rubus1 - + - + - - - 
Vaccinium1 + - - - - - - 
Vitis1,2 + - - - + - + 
Lycium3 - - - - + + + 
Table S3 – List of all the species/varieties and harvest locations of the germplasm collections 
Species Variety/line Harvest location 
Aristotelia chilensis (Molina)Stuntz - Chilei 
Berberis buxfolia Lam.  - Chileii 
Lonicera caerulea L. 260-11 Russiaiii 
Lonicera caerulea L. 838-12 Russiaiii 
Lonicera caerulea L. Avacha Russiaiii 
Lonicera caerulea L. Bazhovskaya Russiaiii 
Lonicera caerulea L. Leningradskii Velikan Russiaiii 
Lonicera caerulea L. Malvina Russiaiii 
Lonicera caerulea L. Morena Russiaiii 
Lonicera caerulea L. Nimfa Russiaiii 
Lonicera caerulea L. Pavlovskaya Russiaiii 
Lonicera caerulea L. S322-23 Russiaiii 
Lonicera caerulea L. Solovey Russiaiii 
Lonicera caerulea L. Start Russiaiii 
Lonicera caerulea L. Suvenir Russiaiii 
Lycium chinense Mill. - Chinaiv 
Ribes spp. L. 1126 United Kingdomv 
Ribes spp. L. 1196 United Kingdomv 
Ribes spp. L. 2174 United Kingdomv 
Ribes spp. L. 2292-1 United Kingdomv 
Ribes spp. L. 644217 United Kingdomv 
Ribes spp. L. - United Kingdomv 
Ribes spp. L. - Chileii 
Ribes aureum Pursh R2-1-2 United Kingdomv 
Ribes bethmontii Jancz. XW6 United Kingdomv 
Ribes distans Jancz. 2269 United Kingdomv 
Ribes divaricatum Dougl. Montana United Kingdomv 
Ribes fuscescens Jancz. XB6 United Kingdomv 
Ribes futurum Jancz. XR4 United Kingdomv 
Ribes giraldii Jancz. B2-3-1 United Kingdomv 
Ribes grossularia L. 1815-21 United Kingdomv 
Ribes grossularia L. 1824-37 United Kingdomv 
Ribes grossularia L. 9492-5 United Kingdomv 
Ribes grossularia L. 96101-1 United Kingdomv 
Ribes grossularoides Maxim. H1-12-1 United Kingdomv 
Ribes holosericeum Otto& A.Dietr. XR2 United Kingdomv 
Ribes irriguum Douglas H1-5-1 United Kingdomv 
Ribes koehneanum Jancz. XR3 United Kingdomv 
Ribes nevadense Kellog - United Kingdomv 
Ribes nigrum L. Ben Alder United Kingdomv 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha 
Almiai Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha x R.nigrum 
subsp. scandinavicum 
Azhurnaya Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha x R.nigrum 
subsp. scandinavicum 
Bolero Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum 
Buraya Dal’nevostochnaya Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha x R.nigrum 
subsp. scandinavicum 
Charovnitsa Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha 
Dochka 
 
Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha x R.nigrum 
subsp. scandinavicum 
Krasa L’vova Russiaiii 
R.nigrum subsp. scandinavicum x R. 
dikuscha 
Lazur’ Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha x R.nigrum 
subsp. scandinavicum 
Malen’kii Prints Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha x R.nigrum 
subsp. scandinavicum 
Mila Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha x R.nigrum 
subsp. scandinavicum 
Monisto Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha x R.nigrum 
subsp. scandinavicum x R.janczewskii 
Muravushka Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha x R.nigrum 
subsp. scandinavicum 
Ocharovanie Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha x R.nigrum 
subsp. scandinavicum 
Orlovskaya serenada Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha x R.nigrum 
subsp. scandinavicum 
Orlovskii Val’s Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha 
Sensei Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha x R.nigrum 
subsp. scandinavicum 
Sharovidnaya Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha 
Syuita Kievskaya Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x  R.nigrum subsp. 
scandinavicum 
Ukrainka Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha x R.nigrum 
subsp. scandinavicum 
Veloi Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha x R.nigrum 
subsp. scandinavicum 
Vospominanie Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha x R.nigrum 
subsp. scandinavicum 
Zelenaya Dymka Russiaiii 
Ribes nigrum subsp. europaeum х R. nigrum 
subsp. sibiricum x R.dikuscha  
Zhuravushka Russiaiii 
Ribes petraeum Wulf. R2-1-2 United Kingdomv 
Ribes rotundifolium Michx. H1-3-1 United Kingdomv 
Ribes rubrum L. Red Poll United Kingdomv 
Ribes rubrum L. 1518 United Kingdomv 
Ribes rubrum L. 1169 United Kingdomv 
Ribes rubrum L. 1196-2 United Kingdomv 
Ribes rubrum L. 1757-2 United Kingdomv 
Ribes rubrum L. Red Wing United Kingdomv 
Ribes rubrum L. S11-3-36 United Kingdomv 
Ribes sativum Syme R7-3-3 United Kingdomv 
Ribes x saundersii Jancz. XB4 United Kingdomv 
Ribes succirubrum Zabel ex Jancz. XW8 United Kingdomv 
Ribes warcewiczii Jancz. R7-3-3 United Kingdomv 
Ribes watsonianum Koehne - United Kingdomv 
Rubus armeniacus Focke [= R. procerus 
auct.]) 
Himalayan Giant United Kingdomv 
Rubus bartonii Newton syn. ‘Ashton Cross’ Ashton Cross United Kingdomv 
Rubus fruticosus L. agg. B13 United Kingdomv 
Rubus fruticosus L. agg. B14 United Kingdomv 
Rubus fruticosus L. agg. Fantasia United Kingdomv 
Rubus fruticosus L. agg. Karaka Black United Kingdomv 
Rubus geoides Sm - Chileii 
Rubus ursinus x R. armeniacus x R. idaeus Black Butte United Kingdomv 
R. ursinus x R.ursinus x R.idaeus x R. 
ursinus x R. allegheniensis x R. argutus 
Kotata United Kingdomv 
Rubus ursinus x R.ursinus x R.idaeus Ollalie United Kingdomv 
Rubus idaeus L. Glen Ample United Kingdomv 
Rubus idaeus L. Glen Fyne United Kingdomv 
Rubus idaeus L. Malling Admiral United Kingdomv 
Rubus idaeus L. Malmer Szedler United Kingdomv 
Rubus idaeus L. Octavia United Kingdomv 
Rubus idaeus L. Polana United Kingdomv 
Rubus idaeus L. Prestige United Kingdomv 
Rubus idaeus L. Tulameen United Kingdomv 
Rubus loganobaccus L.H.Bailey Nectarberry United Kingdomv 
Rubus loganobaccus L.H.Bailey Boysenberry United Kingdomv 
Rubus loganobaccus L.H.Bailey Loganberry United Kingdomv 
Rubus loganobaccus L.H.Bailey LY59-10 United Kingdomv 
Rubus loganobaccus L.H.Bailey Riwaka Choice United Kingdomv 
Rubus loganobaccus L.H.Bailey Sunberry United Kingdomv 
Rubus loganobaccus L.H.Bailey Tayberry United Kingdomv 
Rubus occidentalis L. Black Hawk United Kingdomv 
Rubus occidentalis L. Huron United Kingdomv 
Rubus occidentalis L. Plum Farmer United Kingdomv 
Rubus phoenicolasius Maxim. Wineberry Portugalvi 
Rubus brigantinus Samp. - Portugalvi 
Rubus genevieri Boreau. - Portugalvi 
Rubus henriquesii Samp. - Portugalvi 
Rubus hochstetterorum Seub. - Portugalvi 
Rubus sampaioanus Sudre ex Samp. - Portugalvi 
Rubus vagabundus Samp. - Portugalvi 
Ugni molinae Turcz. Red Pearl Chilevii 
Vaccinium angustifolium Ait. ex Benth Blomidon Chinaviii 
Vaccinium corymbosum L. Bluecrop Chinaix 
Vaccinium darrowii Camp Misty Chinaix 
Vaccinium uliginosum L. - Chinaviii 
Vaccinium virgatum Ait. Climax Chinaix 
Vaccinium vitis-idaea L. - Chinaviii 
 
                                                          
i Sampling location: Coyhaique, Región de Aysén, Chile 
ii Sampling location: Punta Arenas, Región de Magallanes, Chile 
iii Vavilov Institute collection: Pavlovsk, St-Petersburg, Russia 
iv Sampling location: Beijing botanical garden, Beijing, China 
v The James Hutton Institute collection: Invergowrie, Scotland, UK 
vi Propagation site: Fataca Experimental Field, Odemira, Portugal 
vii Sampling location:Mataquito, Región del Maule, Chile 
viii Sampling location: Tahe, Heilongjiang Province, China 
ix Sampling location: Dalian, Liaoning Province, China 
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S1: Materials and Methods 
Plant material and extraction procedure:  A total of 112 different cultivars and species from the 
Aristotelia, Berberis, Lonicera, Lycium, Ribes, Rubus, Ugni and Vaccinium genera grown in different 
locations (see Supplementary Table 1) were harvested manually in the field and kept under cool 
conditions until they were transferred to -20ºC storage. Frozen fruit of each species/cultivar was 
weighed (approximately 50 g) into a solvent-proof blender containing 150 ml of pre-cooled 50ng ml-1 
Morin (Sigma-Aldrich, Gillingham, UK) solution prepared with 0.2% formic acid in methanol 
solution. Samples were then homogenized and subsequently filtered using Whatman filter paper grade 
1. The resulting filtrate was aliquoted and solvent-dried using a speed-vac followed by lyophilization. 
Dried extracts were flushed with N2 and stored at -20ºC until analysis by LC-ToF-MS. 
Phenolic profile determination by LC-ToF-MS:  Dried extracts from each species/cultivar were 
resolubilized in triplicate using 2 ml of a 75% methanol solution with 0.1% formic acid. From these 
extracts, 500 µl were decanted into filter vials, sealed with 0.45 m PTFE-lined screwcap (Thomson 
Instrument Company, London, UK) and transferred into the autosampler. The analysis was achieved 
in positive and negative modes across 9 batches each, using an Agilent LC-ToF-MS system (Agilent 
Technologies, Cheadle, Cheshire, UK) consisting of a quaternary pump (Agilent 1260), a diode-array-
detector (DAD) (Agilent 1260) a temperature control device (Agilent 1260) and a Thermostat 
(Agilent 1290) coupled to an Agilent 6224 time-of-flight (ToF) instrument. Five microliters of the 
sample were injected onto a 2x150 mm (4 µm) C18 column fitted with a C18 4 x 2 mm Security 
Guard™ cartridge (Phenomenex, Torrance, CA, USA). Sample and column temperatures were 
maintained at 4ºC and 30ºC, respectively. The samples were eluted at a flow rate of 0.3 ml min-1 using 
two mobile phases (A: 0.1% Formic acid in dH2O; B: 0.1% formic acid in 50:50 dH2O: Acetonitrile) 
with the following gradient: 0 min 5%B; 4 min 5% B; 32.00 min 100%B; 34.00 min 100% B; 36.00 
min5% B; 40.00 min 5% B.  For optimal electrospray ionization conditions the nebulizer pressure, 
drying gas temperature and drying gas were set to 45 psi, 350ºC and 3 l min-1, respectively.  In 
addition the diode array detection (DAD) was performed at 254, 280 and 520 nm. Morin levels 
(internal standard) were integrated in Agilent Mass Hunter Quan software (v. B.06.00) and all the 
samples with deviations larger than 10% relative to the dataset mean were reinjected. For all samples, 
three aliquots were analysed across three different analytical batches. 
Component detection, peak alignment and integration: All chromatograms were processed identically 
using the Agilent Software Profinder v B.06.00 (Agilent Technologies, Cheadle, Cheshire, UK) which 
combines peak finding and integration algorithms for high-throughput data generation. For positive 
and negative mode data, the batch recursive molecular feature was used with peak extraction 
restricted to 2.1-38.00 mins of the chromatography and a peak threshold set at 15000 counts. The 
algorithm was set-up to include potential adducts of +H, +Na+, +K+ and +NH4+ in positive mode and -
H and +Cl- in negative mode restricting the compounds to a maximum of one charge state. The 
compound ion count threshold was set at two or more ions, and for alignment purposes the RT 
window was set at 0.70% + 0.60 mins and the mass window was set at 25 ppm + 2 mDa. A post-
processing filter to restrict analysis to compounds with more than 15000 counts and present in at least 
3 of the files in at least one sample group (species/line). The find-by-ion options were set to limit the 
extracted ion chromatogram (EIC) to the expected retention time +/- 0.40 minutes. The “Agile” 
algorithm was used for the integration of EIC, with a gaussian smoothing of 9 points applied before 
the integration with a Gaussian width of 3 points. Additionally, peak filters were set at over 15000 
counts and the chromatogram formats were set to centroid when available and otherwise profile. 
Spectrum was extracted at 10% of peak height and excluded if the spectra within the m/z range used 
was above 20% of saturation. Finally a post-processing filter was applied and compounds with less 
than 15000 counts or present in less 3 files in at least one sample group (species/line) were excluded.  
Statistical analyses:  Statistical analyses of all data were performed using GenStat for Windows, 16th 
Edition (VSN international Ltd., Hemel Hempstead, UK). A principal component analysis (PCA), 
based on the correlation matrix was applied to all the QC samples to ensure that the blank, reference 
samples, and berry samples were well separated (data not shown). Two separate analysis of the 
metabolomics dataset on the berry samples were carried out for the positive and negative dataset. A 
PCA, using the correlation matrix, was used to generate PCA plots of the first 4 principal components, 
which were subsequently used for selecting the species samples providing the most separation 
between samples. 
Yeast plasmids, strains and transformation: p426_GAL1pr-GFP-A42 was generated by inserting the 
sequence GFP-A42, obtained by the double digestion of p416_GPDpr-GFP-A42 (kindly provided 
by Ian Macraedie, RMIT University, AU) with BamHI/SmaI, into the p426 vector. p425_GAL1pr-
GFP-A42 was generated by subcloning the sequence GAL1pr-GFP-A42 into the SacI/HindIII 
restriction sites of p425 vector. S. cerevisiae strains used in this study are BY4742 erg6 MATa his3Δ1 
leu2Δ0 lys2Δ0 ura3Δ YBR082c::kanMX4 (EUROSCARF) and BY4742_CDRE-lacZ MATa his3 leu2 
lys2 ura3 aur1::AUR1-C-4xCDRE-lacZ (Prescott et al, 2010). 
 
Yeast growth conditions and extract treatments: Synthetic complete (SC) medium [0.67% (w/v) yeast 
nitrogen base without amino acids (YNB) (Difco) and 0.79 g l-1 complete supplement mixture (CSM) 
(QBiogene)], containing 2% (w/v) glucose was used for growth of Crz1-reporter strain. Crz1 
activation was induced with 1.8 mM MnCl2 (Stathopoulos & Cyert). FK506 (Cayman Chemicals) was 
used as positive control. Synthetic dropout (SD)-LEU-URA media [0.67% (w/v) YNB and 0.54 g l-1 
6-amino acid dropout CSM-ADE-HIS-LEU-LYS-TRP-URA (QBiogene)], supplemented with standard 
concentrations of the required amino acids and containing 1% (w/v) raffinose, were used for growth 
of the AD yeast model. The repression or induction of disease protein expression was carried out in 
medium containing glucose (control, disease-protein OFF) and galactose (disease-protein ON) at a 
final concentration of 2% (w/v).  
A pre-inoculum was prepared in appropriated raffinose or glucose (only for Crz1-activation model) 
medium and cultures were incubated overnight at 30°C under orbital shaking. Cells were diluted in 
fresh medium and cultures were incubated under the same conditions until the optical density at 600 
nm (OD600 nm) reached 0.5 ± 0.05 (log growth phase). To ensure synchronized cells cultures, cell 
suspensions were further diluted according to the equation ODi x Vi = (ODf/(2(t/gt)) x Vf, where ODi = 
initial optical density of the culture, Vi = initial volume of culture, ODf = final optical density of the 
culture, t = time (usually 16 h), gt = generation time of the strain and Vf = final volume of culture. 
Readings were performed in a 96-well microtiter plate using a Biotek Power Wave XS plate 
spectrophotometer.  
 
Growth assays: Yeast cultures were diluted to OD600 nm 0.12 ± 0.012 in fresh medium supplemented 
or not with the indicated concentrations of extracts in a 96-well microtiter plate. After 2 h incubation 
at 30ºC, cultures were further diluted to OD600 nm 0.03 ± 0.003 in medium containing glucose or 
galactose and supplemented or not with extracts. The cultures were then incubated at 30°C with 
shaking for 24 h or 48 h (for the AD model) and cellular growth was kinetically monitored hourly by 
measuring OD600 nm. The areas under the curve (AUC) were integrated using the Origin software 
(OriginLab, Northampton, MA).  
 
β–Galactosidase assays: For quantitative measurements of β–galactosidase activity, OD600 nm of cells 
cultures were recorded just before cell lysis. Cells were then incubated with Y-PER Yeast Protein 
Extraction Reagent (ThermoFisher Scientific) in 96-well microtiter plates for 20 min at 37ºC, after 
which LacZ buffer containing 4 mg l-1 ONPG was added and plates incubated at 30ºC. The OD420 nm 
and OD550 nm was periodically monitored using a Biotek Power Wave XS Microplate 
Spectrophotometer until the development of the yellow color. Miller units were calculated as 
described previously (Garcia et al, 2016). 
 
Fractionation of bioactive fruit extracts: The freeze-dried extract of selected berries (eg Rubus 
genevieri, and Rubus idaeus) were re-suspended in Milli-Q water, filtered and adsorbed onto a semi-
preparation column packed with a C18 resin (PREP C18 55-105 μm 125Å, Waters Co. USA) using an 
AKTA Explorer (GE USA). 0.1% Formic Acid (Sigma, USA) in Milli-Q water was chosen as mobile 
phase A and Methanol (Chromasolv purity≥99.9%, Sigma, USA) as mobile phase B. The approach 
was modified for the different berry extracts (Rubus genevieri, Rubus idaeus) to achieve proper 
fractionation, by tuning the hydrophobicity of the mobile phase (water-methanol). Modifying loading 
and elution mobile phase composition and gradient profile served to generate a maximum number of 
well identifiable peak/fractions for further bio-activity testing (ranging from 12 to 28 fractions). 
Fractions were brought under vacuum using a rapid-vac (Labconco, USA) to remove methanol for 
further bioactivity testing.  
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